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Since ancient times microalgae have represented a source of bioactive molecules that can be harnessed for 
commercial uses. The first use of microalgae by humans dates back 2000 years, when the Chinese used the 
cyanobacteria Nostoc as a food source during a famine (Spolaore et al., 20061). Nowadays, there is a huge interest 
on natural products obtained from marine organisms that can promote the state of health and well-being for humans 
and other animals. 
During my PhD course, in collaboration with the company Arterra Bioscience - Naples, I explored the potential 
industrial applications of some microalgae species, cultivated at the Agriculture Department of the University of 
Naples (Portici, Italy). In this study the attention was mainly focused on the characterization of two microalgae 
species: Arthrospira maxima and Galdieria sulphuraria. The microalga A. maxima, commercially known as 
Spirulina, is rich in protein and other essential nutrients, such as phenolic acids, tocopherols and β-carotene, which 
are known for their antioxidant properties. G. sulphuraria is a thermophile unicellular microalga, that lives in 
extreme conditions of temperature and acidity.  
The study on Spirulina is described in chapter 1, while the characterization of G. sulphuraria ended up with a patent 













Microalgae are microscopic photosynthetic organisms that produce a wide range of metabolites, such as proteins, 
fatty acids, carbohydrates, carotenoids and vitamins, useful for different specific industrial applications, including 
health care, food, cosmetics and energy production. The cyanobacteria Spirulina (Arthrospira maxima) is one of the 
most promising source of important metabolites, particularly proteins, lipids and phytochemicals, thus it was the 
focus of the research aimed at developing new active ingredients for health care applications.  
In order to obtain valuable products from Spirulina, a total lysate, obtained from the microalga, was subjected to 
three types of fermentation processes: one based on the use of indigenous bacteria (auto-fermentation), those 
developed spontaneously in the lysate; the second based on the use of the mix Yovis® (Sigma-Tau), added after a 
sterilization procedure of the lysate; and the third performed by employing enzymes (carbohydrase and Alcalase), 
thus without using any microorganism. 
The three extracts obtained from the fermentation processes were investigated for their antioxidant activity in 
protecting human cells against free radicals, then, more specifically, for inducing hydration and reduce dehydration 
in cultured skin cells. The results of the study underlined that the Spirulina extracts, either those derived from 
microbial treatments or enzymatic digestion, were significantly more efficient than the untreated samples in 
protecting cell membrane from oxidative stress. Moreover, those extracts obtained by enzymatic treatment showed 
the best hydrating and moisturizing capacity.  
In conclusion, the products derived from Spirulina fermentation have potential applications in both the cosmetic 
field, as hydrating and moisturizing agents for skin care, and nutraceutics, as food supplements that increase the 















Microalgae or microphytes are microscopic photosynthetic organisms, typically found in both freshwater and 
marine environments. Microalgae are classified as Protists. They are unicellular or multicellular organisms without 
specialized tissues; this simple cellular organization distinguishes the Protists from other eukaryotes, such as fungi, 
animals and plants. They exist individually or in chains and groups, and their sizes can range from one to few 
hundreds micrometers, depending on the species (Fig.1). Like plants, microalgae contain chlorophyll and are 
capable to convert light to chemical energy via photosynthesis. They are essential for life on earth because they 
produce approximately half of the atmospheric oxygen and use simultaneously the greenhouse gas carbon dioxide to 
grow photo-autotrophically. In the past, natural waters (lakes, lagoons, ponds) or artificial ponds were used to grow 
algae, more recently closed photobioreactors have been employed. Today, a range of microalgae species is produced 
in hatcheries and is used in a variety of ways for commercial purposes. Studies have estimated main factors in the 
success of a microalgae hatchery system as the dimensions of the container/bioreactor where microalgae are 
cultured, exposure to light/irradiation and concentration of cells within the reactor (Xu et al., 20092).  
 
Figure 1. Different examples of microalgae: Chlorella vulgaris (A); Haematococcus pluvialis (B); Galdieria 
sulphuraria (C); Spirulina platensis (D). 
 
Microalgae contain numerous bioactive compounds that can be exploited for commercial use. Most part of 
microalgae species can be used to produce a wide range of metabolites such as proteins, fatty acids, carbohydrates, 
carotenoids or vitamins for health, food, cosmetics and for energy production (Priyadarshani and Biswajit, 20123). 
The chemical composition of microalgae is not a constant factor but on the opposite varies over a wide range, both 








synthesize desired compounds by changing environmental factors, like temperature, illumination, pH, CO2 supply, 
salt and nutrients, especially those compounds that are essential for human and animal diet (Danesi et al., 20044; 
Colla et al., 20075; Ogbonda et al., 20076). For example, the large variety of fatty acids, such as the omega-3, 
produced by several species of microalgae represent the basic foodstuff for numerous aquaculture species, especially 
filtering bivalves and fish, which are unable to synthesize them by their own. 
Besides the use of microalgae as food for cultured aquatic species, they have been very important for human diet as 
well, thus microalgae production has become central in many commercial applications concerning food and health 
care, with the consequent need of increasing production techniques and productivity. Compared to other natural 
sources of bioactive ingredients, microalgae have many advantages such as their huge biodiversity, the possibility to 
grow in arid land and with limited fresh water consumption and the flexibility of their metabolism, which could be 
adapted to produce specific molecules. All these factors led to very sustainable production making microalgae 
eligible as one of the most promising foods for the future, particularly as source of proteins, lipids and 
phytochemicals (Buono et al., 20147). Table 1 reports a comparison of the general compositions of human food 
sources with that of different algae. 
 
Table 1. General composition of different human food sources and algae (% of dry matter) (Becker, 20078). 
 
1.1.1 Microalgae in nutraceutics and cosmetics 
The oldest documented use of microalgae as food was 2000 years ago, when the Chinese used the cyanobacteria 
Nostoc as a food source during a famine (Spolaore et al., 20061). Another type of microalgae, the cyanobacteria 
Arthrospira maxima was a common food source among populations in Chad and Aztecs in Mexico as far back as the 
16th century (Whitton, B., and M. Potts. 2000. The ecology of Cyanobacteria: their diversity in time and space9). 
Since the past, cultured microalgae were used as direct feed for humans and land-based farm animals, and as feed 
for such as fish and crustaceans. Commercial use of microalgae as sources of speciﬁc chemicals began with D. 
salina for the production of β-carotene in the 1970s (Borowitzka and Borowitzka, 198910) followed by the use of 
Haematococcus pluvialis as a source of astaxanthin (Lorenz and Cysewski, 200011) and Crypthecodinium cohnii for 
long-chain polyunsaturated fatty acid (PUFA) and docosahexaenoic acid (DHA) (Kyle et al., 199812). On the other 
hand, interest in applied algal culture continued with studies on the use of algae as photosynthetic gas exchangers 
for space travel and for generating renewable energy sources (Pulz and Scheibenbogen 199813; Borowitzka 199914). 






and fresh water organisms, that can promote health and well-being (Sloan, 199915). Microalgae are a potentially 
great source of natural compounds, such as carotenoids, phycobilins, fatty acids, polysaccharides, vitamins that 
could be used as biologically active compounds (Gouveia et al., 200516). When foods or part of them have these 
properties, they can be generically named as functional foods. The concept of functional food was developed at the 
beginning of the 80s in Japan, as a way to reduce the high health costs derived from a population with high life 
expectations (Arai, 199617). In Europe, in the second half of the 90s, a working group coordinated by the European 
Section of the International Life Science Institute (ILSI), and supported by the European Commission, was created 
to promote inside the IV Framework Program the action FUFOSE (Functional Food Science in Europe) to stimulate 
the scientific study on functional foods. From this project a definition for functional food was generated. Namely, a 
food can be considered "functional" if, besides its nutritious effects, it has a demonstrated benefit for one or more 
functions of the human organism, improving the state of health or well-being or reducing the risk of disease 
(Diplock et al., 199918; Kalra, 200319). In this definition it is necessary to emphasize three important and new 
aspects: a) the functional effect is different that the nutritious; b) the functional effect must be demonstrated 
satisfactorily; c) the benefit can consist in an improvement of a physiological function or in a reduction of risk of 
developing a pathological process. Besides, functional foods must have a series of additional characteristics as, for 
instance, the need of effectiveness in their beneficial action at the normal consumed doses. The beneficial action 
exercised by functional foods is due to a component or a series of ingredients that either are not present in the 
analogous conventional food or are present at lower concentrations. These ingredients are called functional 
ingredients. 
Nowadays, over 470 nutraceutical and functional food products are commercially available (Eskin and Tamir, 
200520) (Table 2). The current estimated global market size for nutraceutical products is 30 to 60 billion dollars, 
primarily in the United States, Japan, and Europe, with a potential short-term growth market demand of over 197 
billion dollars (Benkouider, 200521). Different types of microalgae are well known to be used as food supplements 
and nutraceuticals, such as Nostoc (Deng et al., 200822), Botryococcus (Dayananda et al., 201023), Chlamydomonas, 
Scenedesmus (Ceron-Garcia et al., 201024) and Porphyridium (Dvir et al., 200925), especially for their capability of 
producing necessary vitamins including: A (Retinol), B1 (Thiamine), B2 (Riboflavin), B3 (Niacin), B6 
(Pyridoxine), B9 (Folic acid), B12 (Cobalamin), C (L-Ascorbic acid), D, E (Tocopherol), and H (Biotin). 
Besides the food market, the use of microalgae has been established in cosmetic market as well. The use of algal 
proteins or derivatives is important in conferring moisture retention on hair and skin, since they show a strong 
affinity with hair or skin to improve their nourishments. In particular, the extracts form Arthrospira and Chlorella 
are examples of microalgae already characterized in the skin care market (Stolz and Obermayer, 200526): Protulines 
(Exsymol, Monaco) is a product from Arthrospira with the function of repairing the signs of early skin aging, while, 
Dermochlorella (France) is an extract from Chlorella vulgaris, involved in collagen synthesis in the skin. Two new 
products were launched by Pentapharm (Basel, Switzerland): an extract from Nannochloropsis oculata with skin-
tightening properties and an ingredient from Dunaliella salina, which showed the ability to stimulate cell 
proliferation and turnover and to positively influence the energy metabolism of skin (Stolz and Obermayer, 200526). 
More recently, a new characterization for cosmetic activities regarded an extract derived from the microalga 
Botryococcus braunii, suggesting that a B. braunii water soluble extract could improve skin barrier function and 
prevent premature skin ageing (Buono et al., 201227). Other examples of microalgae species used in cosmetic 
products are Ascophyllum nodosum, Alaria esculenta and Chondrus crispus. Ascophyllum nodosum shows anti-
aging, anti-wrinkles and anti-puff properties (CAS #84775-78-0). Kalpariane represents a product from Alaria 
esculenta extract with the anti-aging anti-collagenase and anti-elastase activities, thanks to its high concentrations of 
fatty acids (Verdy et al., 201128). Moreover, Carrageenan extract, from alga Chondrus crispus, is an excellent 














1.1.2 Biotechnological processes applied to microalgae 
In order to obtain functional foods, food products were initially enriched with vitamins and/or minerals, such as 
vitamin C, vitamin E, folic acid, zinc, iron, and calcium (Sloan, 200030). Later, the approach changed by the addition 
of several micronutrients such as omega-3 fatty acids, linoleic acids, phytosterols, soluble fibres (inulin and fructo-
oligosaccharides, called prebiotics), trying to promote consumers health or to prevent different diseases (Shahidi, 
200431; van Kleef et al., 200532, Sloan, 200233). Also, foods can be changed to contain viable microorganisms that 
can benefit human health; these products are called probiotics and are able to improve the activity in the intestinal 
tract and the immune system, among other functions. Lactic acid bacteria including Lactobacillus acidophilus, L. 
johnsonii, L. reuteri, L. casei shirota, etc., represents the microorganisms usually added to the food (Sanders, 
200034). Novel bio-processing technologies are developing for isolation of some bioactive substances with bioactive 
properties. Some of them involve certain bio-transformation processes mediated by enzymes and microorganisms 
(Kim and Mendis, 200635). The process by which microorganisms and their enzymes bring about these desirable 
changes in food materials is known as fermentation. Technically, fermentation is a metabolic process in which an 
organism converts a carbohydrate, such as starch or a sugar, into an alcohol or an acid. The bacteria use food as a 
substrate for their propagation. Natural fermentation precedes human history; the earliest evidence of a fermentation 
process started with the production of yogurt, bread and wine (Hutkins, 200836). Since the earliest evidences, 
fermentation, applied to foods, was mainly processed to enhance properties such as the taste, aroma, shelf-life, 
texture and nutritional value of foods. Nowadays, fermentation and enzymatic digestion represent the most utilized 
biotechnological approach for the development of new bioactive ingredients (Shahidi, 200937). There are several 
industrial applications of fermented products. Fermentation has been reported to lead to antioxidant peptides in 
soybean (Wang et al., 201438), polyphenols like theaflavins and tearubigins in black tea (Halder et al., 199839), 
isoflavanoids in beer (Lapcik et al., 199840) and phenolic compounds in beans (Chung et al., 200241), flavonoids, 
flavonols, and several phenolic acids contained in red cabbage sprouts (Hunaefi et al., 201342). Fermented soybean 
products such as natto, tempeh, and douche also contain antioxidative peptides due to the action of fungal proteases 
(Wang et al., 200843). During the fermentation of soybean by fungi, isoflavone glycosides are hydrolysed to release 
free isoflavone aglycone by fungal β-glucosidase (Chiou and Cheng, 200144) and therefore render health benefits to 
fermented soybean products. Black tea fermentation has been reported to lead to the formation of theaflavins and 
thearubigins, which are polyphenols that account for the various characteristics of black tea. The volatile aroma in 
the black tea is also associated with fermentation, which leads to the formation of volatile aroma aglycones (Halder 
et al., 199839). It is widely known that tea possess antioxidant, anticancer, anti-inflammatory and antimicrobial 
properties; all these activities may be associated with fermentation (Shahidi, 200937). In fermented marine food 
sauces such as, blue mussel sauce and oyster sauce, enzymatic hydrolysis has already been done by microorganisms, 
and bioactive peptides can be purified without further hydrolysis. In addition, marine processing by-products 
contain bioactive peptides with valuable functional properties (Kim and Mendis, 200635). 
Besides the use of fermented products, the addition of a specific enzyme to some plant derivatives has been 
recognized in the food industry, and the main objective is to improve the utilization of nutrients from raw materials, 
leading to value-added processed products. Over the last decade, the use of plant protein hydrolysates in human 
nutrition has broadly expanded. They are often used in different nutritional formulations, such as supplementation of 
drinks to enhance their nutritional and functional properties, or special medical diets. Proteins are essential 
components because they are a source of amino acids useful for growth and maintenance and provide functional 
properties to foods. Due to the increasing costs and limited supplies of animal proteins, and since vegetable protein 
is the most abundant source of protein on Earth, a number of vegetable proteins have been investigated for possible 
incorporation into formulated foods (Hrckova et al., 200245). In general, food proteins are hydrolysed for many 
reasons ranging from the improvement of nutritional and functional properties, texture characteristics to the removal 
of odour, flavour, and toxic or components with low nutritional value. Since the obtained peptides have a smaller 
molecular size than proteins, thus their functional properties are different: increased solubility over pH range, 
decreased viscosity, and significant changes in foaming, gelling and emulsifying properties. Most of the basic 






fermentation technology, fermented food items produced from algae have yet to be developed. Many studies were 
conducted on methane fermentation of seaweeds during the 1970s and 1980 (Aquaculture Associates, 198147), but 
few researches were conducted on fermentation of algae for foods production. Nowadays, there is great interest on 
the potential use of microalgae to produce biofuels through biotechnological technologies (Goh and Lee, 201048). A 
recent study on Chlorella cell wall degradation enhances its using in biofuels production (Gerken et al., 201249). 
Under nitrogen starvation, Scenedesmus obliquus is able to accumulate carbohydrates to be used for bioethanol 
production (Ho et al., 201250). One of the few examples of cosmetic application of a fermented algae is represented 
by peptides or protein hydrolysates derived from Porphyra spp. and wakame seaweeds under appropriate conditions 
(Hagino and Saito, 201051). 
 
1.2 Arthrospira maxima - Spirulina  
Arthrospira maxima, usually named Spirulina, is the best known and most cultivated genus of Cyanobacteria 
because of its unique nutritional properties. Cyanobacteria are Gram-negative photosynthetic prokaryotes with a 
long evolutionary history. Spirulina is a ubiquitous blue-green microalgae, where cells are joined from end to end to 
form twisted filaments (Fig. 2). They are generally found in tropical and subtropical regions in warm water bodies 
with high alkalinity. The blue-green colour of these microalgae is due to a mix of photosynthetic pigments like 
chlorophyll, carotenoids and phycocyanin, the latter one is responsible for the blue color of the organism. 
Figure 2 . Spirulina maxima cultivated in a microalgae pilot plant at Agriculture Department of University of 
Naples (Portici, Italy). 
 
The blue-green microalgae Spirulina, was an important source of nutrients in the traditional diet of natives of Africa 
and Mexico. It has been found to be a rich natural source of proteins, carotenoids, Ω-3 and Ω-6 polyunsaturated fatty 
acids, provitamins, and other nutrients such as vitamin A, vitamin E, and selenium (Wu et al., 200552). Two main 
species are known: A. plantensis and A. maxima. Arthrospira whole biomass and extracts are reported to show 
various biological properties due to their bioactive compounds. Proximate analysis of Spirulina was started in the 
1970s and it indicated that this microalgae was an excellent source of proteins and was also rich in other nutrients 
(Becker, 20078). Table 3, indicates the different proximate analysis results from different institutions and producers. 
The entire genome of Arthrospira maxima, with a genome size of 5.4 Mb, has been sequenced and is available 







  Table 3: Proximate analysis of Spirulina. Source: FAO 2008. 
 
1.2.1 History 
Arthrospira maxima has a history of being consumed along the alkaline lakes of Chad and Niger and also by the 
Aztecs living in the valley of Mexico. The Aztecs referred to it as Tecuitalat meaning stone excrement, while in 
Chad it was called Dihe and was sold in the local markets as dried cakes. 
The first commercial large-scale production of Spirulina was in the early 1970s in Texcoco, Mexico. Nowadays, it is 
commercialized in the market of most countries around the world. The largest commercial producers of Spirulina 
are located in the United States, Thailand, India, Taiwan, China, Pakistan, Burma (a.k.a. Myanmar), Greece and 
Chile. 
 
1.2.2 Spirulina culturing and industrial applications 
Spirulina grows quickly and produces 20 times more protein by surface unit than soy beans (Henrikson, 199453). 
When comparing the growth of Spirulina and the agricultural crop cycles, the difference in the time of production is 
noticeable. In agriculture, the harvest is obtained after several months of cultivation, while Spirulina is continually 
produced (Switzer, 198054). 
The cultivation and the production of Spirulina can be in closed or in open systems; closed systems include 











Figure 3: Different techniques of production of Spirulina: in open pond (on the left) and in bioreactors (on the 
right). 
 
Zarrouk medium (Zarrouk, 199655) is the most commonly used medium for Spirulina and also preferred for 
industrial production. The main factors to consider during the cultivation of Spirulina are: luminosity, temperature, 
inoculation size, stirring speed, dissolved solids, pH, water quality, macro and micro nutrients presence (Sanchez et 
al., 200356). In particular, Spirulina, such as other microalgae, are organisms that live in complex habitats submitted 
to extreme conditions (changes of salinity, temperature, nutrients, UV-vis irradiation). Therefore, they must adapt 
rapidly to the new environmental conditions to survive, producing a great variety of secondary metabolites, 
biologically active, which cannot be found in other organisms. Moreover, it is possible to induce microalgae to 
synthesize desired compounds by changing environmental factors, like temperature, illumination, pH, CO2 supply, 
salt and nutrients. It means we could use them as natural reactors, leading to an enrichment of some bioactives 
(Plaza et al., 200957). 
Spirulina has found wide applications in diverse areas such as agriculture, food, pharmaceuticals, perfumeries, 
medicine and science. Since the past, it is used as fertilizer of depleted soils because of its natural nitrogen content 
(Littler et al., 200658). The biomass of blue-green algae is also used as feed for farm animals and birds (Spolaore et 
al., 20061). Arthrospira, like other microalgae, has been considered recently as a promising biomass feedstock with 
great potential for biodiesel production, especially because of its easy culture system, it can achieve high cell 
densities and can produce fatty acids efficiently (EL Shimi et al., 201359). Biologically produced fuel is gaining 
popularity as fossil fuels are becoming more expensive and scarce. Therefore, its role in bioremediation and 
wastewater treatment is an emerging area of interest (Fig. 4). 
Moreover, Spirulina has a long history of safe usage as food and food supplement because of its nutritional value 
(Belay, 200260). It is classified as GRAS (Generally Recognized as Safe) by FDA (Food and Drug Administration), 











Figure 4. Examples of industrial applications of Spirulina. 
 
 
Nowadays, a lot of attention is focused on the use of nutraceuticals, which includes food and supplement products 
that claim to provide health benefits beyond their basic nutritional value (Kim and Wijesekara, 201061). Faithful to 
this model, the cosmetic industry during the past 10-15 years has observed a gradual shift in the use of ingredients 
towards more biologically derived products or products of fermentation processes. Today, consumers are more 
aware of nutritional products that contribute to both skin health and disease prevention. Cosmetics companies are 
making huge investments in biotechnology to create advanced products able to promote welfare and quality of life, 
with an extra touch of nutrition. 
However, there is growing demand to isolate new function proteins or bioactive peptides from microalgae. 
Therefore, much of the work on bioactivity of microalgae especially on Spirulina has been on the entire biomass 
(Harnedy and FitzGerald, 201162). Some algae species have induced biological activities, which are associated with 
proteins, protein hydrolysates or peptides that can affect their standing beyond their nutritional values. Their 
bioactivities make them potential candidates for multifunctional applications such as functional food, nutraceuticals, 
pharmaceuticals and cosmetic ingredients.  
It has been claimed that Spirulina and its extracts have various health promoting effects: such as preventing cancers, 
the alleviation of hyperlipidemis, suppression of hypertension, stimulate the immunological system, growth 
promotion of intestinal Lactobacillus, reduce the nephrotoxicity of pharmaceuticals and toxic metals and provide 
protection against the harmful effect of radiation (Belay et al., 199363), suppression of elevated serum glucose level. 
These properties have been attributed to different compounds such as phenolics, phycobiliproteins, carotenoids, 
organic acids, sulphated polysaccharide spirulan and polyunsaturated fatty acids (Vonshak, 199764; Khan et al., 
200565). For these reasons, A. platensis is widely used in commercial cultivation (Dejsungkranont et al., 201266). 
Besides, it has also been reported to have antimicrobial activities against some pathogenic bacteria (Mendiola et al., 
200767). Antioxidative phycocyanin and phycocyanobilin are isolated from Arthrospira platensis. Phycocyanin, one 
of the major constituents of A. platensis responsible for its biological activity, has significant antioxidant and anti-
inflammatory properties (Bhat and Madyastha, 200068). Phycocyanobilin, an open chain tetrapyrrole chromophore 
covalently attached to the apoproteina constituent of phycocyanin in A. platensis, plays an important role in some of 
the biological properties exhibited by phycocyanin. Thus, the characterization of phycocyanobilin and its separation 
from A. platensis are worthwhile for increasing its attractive biological and commercial possibilities. 
Concerning the cosmetic application, the high protein content of Spirulina represents a requested source of essential 
amino acids that constitute collagen and, moreover, can contribute to the maintenance of the hydrated and 






Spirulina is also one of the few microorganisms that contain γ-linolenic acid, which is a rare fatty acid that is 
believed to prevent the frequency and severity of acne outbreaks and keep skin fresh and healthy looking.  
Cosmetics companies use biotechnology both to discover and manufacture cosmetic active ingredients, which are 
then evaluated for efficacy on skin cell cultures and on human skin in vivo. Among the range of activities highly 
requested by the cosmetic market, particular attention is focused on products having high antioxidant activity, in 
term of protection of the skin against free radicals, and high hydration capacity, which is the ability to retain and 
uniformly distribute the moisture throughout the different skin layers.
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AIM OF THE THESIS 
2. AIM OF THE THESIS 
Microalgae are one of the most promising sources of active ingredients for industrial applications, such as functional 
food and skin care products. They contain a wide range of secondary metabolites that can be used as biologically 
active compounds. 
In the present study we chose Spirulina (Arthrospira maxima) as source of active molecules to develop products 
with potential applications in human health care. Since ancient times, Spirulina has been used as nutraceutical 
product thanks to its high content of protein. Based on this assumption, Spirulina was subjected to biotechnological 
processes, such as auto-fermentation, lactic acid fermentation and enzymatic digestion. The main goal of my PhD 
thesis was characterizing biologically and comparing the different products derived from these processes to develop 
new active ingredients with specific properties for food and/or cosmetic applications. 
Arterra Bioscience srl, an Italian research-based biotech company, was chosen as partner of my PhD program, since 
it has strong expertise in developing new active ingredients with industrial applications, ranging from cosmetics to 
agriculture. 
Spirulina biomass was cultured in open ponds at Agriculture Department of University of Naples, then fermented at 
Microbiology Department of University of Naples (Portici) in collaboration with the group of Prof. Ercolini. Finally, 
Spirulina derived extracts were analysed for the different biological activities, concerning antioxidant, hydration and 
moisturizing activities, at laboratories of Arterra Bioscience srl. 
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3. MATERIALS AND METHOD 
3.1 Cultivation of Spirulina 
Arthrospira maxima (Spirulina), strain SAG 84.79 (University of Göttingen, Germany), was cultivated in a 
microalgae pilot plant at Agriculture Department of University of Naples (Portici, Italy) in July of 2012. Spirulina 
was cultured in open pond (deep 25 cm, total volume 2500 L/pond) using Zarrouk medium (Zarrouk, 196655) and 
the parameters at harvesting were: pH 10.2 ± 0.2, temperature 27.5 ± 2.2°C, mean daily irradiation of 25.3 
MJ/m2/die, OD560 1.0±0.1, conductivity 24.2 ±1.4 mS/cm. NaHCO3 and NaCl were food grade; KNO3 and K2HPO4 
were technical grade; K2SO4, CaCl2, EDTA, MgSO4, FeSO4 and A5 solution were of analytical grade supplied by 
Sigma Aldrich (Milan, Italy). The biomass was harvested using a pre-filter of 380 µm and a nylon filter of 47 µm 
and washed three times with sterile water to reduce salts content. After washing Spirulina biomass was pressed to 
remove the highest possible amount of interstitial water, packed in plastic bags and finally frozen at -20 °C. Dry 
weight (DW) of samples was obtained gravimetrically at 105 °C overnight. Nutritional analyses made with standard 
methods on Spirulina dried in vented oven at 52 °C for 5 h are reported in table 4. The tools in contact with the 
microalgae were properly sterilized in order to minimize the possible contamination throughout the process. 



















Table 4. Nutritional analysis of A.maxima dried in vented oven at 52 °C for 5 h. 
 
3.2 Sample preparation 
Fresh biomass containing 30g of dry Spirulina per litre of distilled water was prepared. Further, this initial 
preparation was used to obtain various samples, as reported in the flowchart of figure 5. The samples were denoted 
as reported in table 6. 
Nutrition values of A. maxima oven-dried 
Values in g/100 g of products 
Protein 56.8 
Total Fat 6.6 
    Saturated Fat 2.7 
Total carbohydrate 16.9 
    Dietary fiber 7.3 
Moisture 9.24 
 C-phycocyanin 6.3 






Vitamin B12 (mg/100g) 2.6 
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3.2.1 Crude extract 
Fresh biomass has been thawed in the refrigerator at 4 °C. The biomass was then diluted with MilliQ water to speed 
up the thawing and breaking. For an efficient extraction, some glass-beads were put inside the biomass sample. The 
extracts were centrifuged at 4000 rpm for 15 minutes to separate the pellet from the supernatant. For the purpose of 
this thesis, Spirulina extract refers to the supernatant sample that was lyophilized directly without being subjected to 
other processes. 
 
3.2.2 Auto-fermented sample 
The initial biomass (30g/L) was set to undergo natural fermentation without addition of inoculum. Biomass contains 
some native bacteria that provoke fermentation in culture conditions. The microflora associated with Spirulina crops 
is generally scarce and non-pathogenic. In fact, the high alkalinity of the crop environment  (pH 10-11) is an 
excellent barrier against contamination, e.g. by bacteria, yeast, fungi or algae. The fermentation was allowed to take 
place at 37 °C and samples were taken at time 0 and 24 hours. These samples were denoted as SEA (Spirulina 
extract auto-fermented). 
 
3.2.3 Fermentation mediated by Yovis® 
The initial biomass was divided into 2 batches and subjected to autoclaving at 121 ºC for 15 minutes. One of the 
samples was subjected to analysis after autoclaving without further treatment (no inoculation) and was denoted as 
SEA. The other batch was fermented using a commercial probiotic mix Yovis®. 1g of Yovis® was dissolved in 
100ml of solution and then added (800ml) to the autoclaved Spirulina biomass. The biomass was then incubated at 
37 °C and samples were taken at time 0 and 48 hours. This sample was denoted as SEA-Y. 
 
3.2.3.1 Commercial Probiotic mix (Yovis®) 
Yovis®, a commercial probiotic mix from Sigma-Tau (Italy), was used for the fermentation of samples. 1g of the 
mix contains the following concentration of freeze dried bacteria: 
• S. salivarius subsp. Thermophilus. minimum 2.04 x 1011 cfu 
• Bifidobacteria (B. breve, B. infantis, B. longum) minimum 9.3 x 1010 cfu 
• L. acidophilus minimum 2 x 109 cfu  
• L. plantarum minimum 2.20 x 108 cfu 
• L. casei minimum 2.20 x 108 cfu 
• L. delbrueckii subsp. bulgaricus minimum 3 x 108 cfu 
• S.faecium minimum 3 x 107 cfu 
3.2.4 Enzymatic digestion 
Spirulina suspension was prepared by adding 25 ml of distilled water to 1 g of Spirulina. The suspension was 
adjusted to pH 6 using 1 N NaOH and stirred in the presence of magnetic beads for 4 hours at 10-15 °C to provoke 
microalgae breaking. For carbohydrates treatments, Spirulina suspension was mixed with 50 mM citrate buffer (pH 
5.0) in 125-ml Erlenmeyer flasks at a loading rate of 2 % w/v. Hydrolysis was carried out in a water bath at 50 °C 
for 2 hours. All treatments were conducted in triplicate. Aliquots (500 µl) were taken to measure the amount of 
sugar content. 
Then, 10 ml of 1 M potassium phosphate buffer (Na2HPO4/NaH2PO4, pH 7.5) and sodium azide (0.1%, w/v) was 
added to the mixture and stirred using a magnetic stirrer. The pH of the mixture was adjusted to 7.5 with 1 N NaOH. 
The flask was then placed in a water bath shaker operating at 140 rpm. The enzymatic hydrolysis was started by 
adding 420 mg (1259 U/L) of Immobilized Alcalase (Novozyme, Novo Nordisk, Bagsvaerd, Denmark) and carried 





MATERIALS AND METHODS 
primary ammines was measured through OPA test. 
 
3.2.4.1 OPA assay 
In order to understand if enzymatic digestion was overcome, an OPA (o-Phthaldialdehyde) assay was performed. A 
solution of 10 mg of o-Phthaldialdehyde, 10 µl of β-mercapthoethanol, 200 µl EtOH, 20 ml Na2CO3 50 mM pH 10.5 
was prepared. A series of dilutions ranging from 0 µg/ml to 2 µg/ml of Glycine (Gly) were made using deionized 
water. Samples and standards were placed in cuvettes with 1 ml of OPA reagent solution and incubated for 2 
minutes, thoroughly shaking at room temperature. The OPA solution reacted with the primary amino groups and 




After several processes, all the samples were centrifuged at 4000 rpm for 15 minutes to separate the pellet from the 
supernatant. The later was used in subsequent experiments. The supernatant was used based on the hypothesis that it 
contains molecules such as small peptides, reported in literature to possess high bioactivity. 
 
3.3 Microbiology analysis 
The objective of this experiment was to determine the presence and activity of microorganisms involved in the 
fermentation process of Spirulina. The samples used for the microbiological analysis were directly taken at time 0 
and at time points of 24 and 48 hours after the fermentation. The samples were not subjected to centrifugation and 
various dilutions were prepared using ringer solution and standard plate count method. 
 
3.4 Oxygen radical absorbance capacity (ORAC assay) 
In order to calculate the antioxidant power of the extracts, we performed an in vitro Oxygen Radical Absorbance 
Capacity (ORAC) assay. 25 µl of compound dilution in phosphate buffer was aliquoted into 96 well plate and 150 µl 
of fluorescein solution, 8.5 nM in phosphate buffer, was added to each sample. After incubation at 37 °C for 15 min, 
25 µl of AAPH solution (153 mM in phosphate buffer) was pipetted into each well and the progress of the reaction 
was monitored at 535 nm, using a fluorescence multiwell reader (EnVision, PerkinElmer). The fluorescence was 
measured every minute for 60 min. Antioxidant power of the mixture was calculated according to the method 
described by Huang et al., 200270. The net area under the curve (AUC) of the samples and standards, represented by 
different dilutions of 6-hydroxy-2,5,7,8-tetramethylchroman2-carboxylic acid (Trolox) was calculated. The standard 
curve was obtained by plotting Trolox concentrations against the average net AUC of the two measurements for 
each concentration. Net AUC was obtained by subtracting the AUC of the blank from that of the sample or the 
standard. ORAC values of the samples were expressed as µmol of Trolox equivalents (TE) per g of lyophilized 
extract. 
 
3.5 SDS-PAGE analysis 
Electrophoresis of all extracts fractions were carried out in the Mini-PROTEAN II (BIO-RAD, USA) using 15% 
polyacrylamide gel with SDS (SDS- PAGE) (Laemmli, 197071). The concentration of the stacking gel was 5%. The 
marker (BIORAD, Precision Plus Protein M.W. 10kDa-250kDa) was used to identify the approximate size of the 
bands. The samples were prepared by adding 30 µl of loading buffer (SDS reducing buffer: 125 mM Tris-HCl, pH 
6.8; 4% of SDS, 10% β-mercaptoethanol, 20% glycerol, 0.2% (w/v) of bromophenol blue) to 10 µg of protein of 
each extract and heating for 5 min at 95 °C. Further, 30 µl of each sample and 10 µl of marker were applied onto gel 
into different wells. Following electrophoresis (100 V for 60 min in Tris-glycine pH 8.4) the gel was stained in 
0.25% (w/v) Coomassie blue R-250 (Sigma) in methanol:acetic acid:water solution (50:10:40) for 1 h and destained 
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3.6 BIOACTIVITY ANALYSIS 
3.6.1 Cell viability assay 
In order to estimate the cytotoxicity of the different preparations, we performed cell viability assay (MTT) on 
murine immortalized fibroblasts (NIH3T3, murine embryonic ﬁbroblasts, ECACC, Salisbury, UK) and on 
immortalized keratinocytes (HaCaT), according to the method described by Mosmann et al. (198372). The MTT (3-
(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide) enters the cells and passes into the mitochondria, 
where it is reduced to an insoluble, colored, dark purple formazan product. Only viable cells with active metabolism 
convert MTT into the formazan product. Treatments were performed with different concentrations of Spirulina 
extracts (from 0.5 to 0.01 g/L). The keratinocytes were seeded at density of 1.8 x 105 and fibroblasts at density of 
1.5 x 105 in the 96 well plates. After 8 hours, the ingredients were added to the cells for 48 hours. The plates were 
incubated at 37 °C and 5% CO2. After 48 hours of treatments, the media was carefully removed and the cells rinsed 
with PBS (Phosphate buffered saline). The cells were incubated with 100 µl/well of sterile MTT solution I, 
containing: 10 mM Hepes, 1.3 mM CaCl2, 1 mM MgSO4, 5 mM glucose and 0.5 mg/ml of colorimetric substrate 
(MTT) in PBS buffer at pH 7.4. The plates were incubated for 3 hours a 37 °C in dark. The cells were then 
solubilized with 100 µl/well of MTT solution II, containing: 10% TritonX100, 0.1 N HCl in isopropanol, and the 
plate incubated overnight at room temperature. The developed colour was then quantified at 595 nm by a multiwell 
spectrophotometer Victor3 (PerkinElmer). The absorbance values were normalized by setting the control group 
(untreated cells) to 100%. Subsequently, the viability of the treated cells was expressed as a percentage of untreated 
cells (Fig. 8). 
All materials were obtained from Sigma-Aldrich. 
 
3.6.2 Membrane ROS (Lipid peroxidation) 
1.5 × 104 NIH3T3 cells, maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 10% FCS under 5% CO2 
at 37 °C, were seeded in 96 well plates and grown for 20 h to let them attach to the bottom of the well. The cells 
were then incubated with different concentrations of Spirulina extracts or Tocopherol (Vitamin E) 100 µM, used as 
positive control, for 2.5 h. At the end, the cells were washed in PBS and the cell auto-ﬂuorescence value 
(background) measured at the plate reader, using 490 nm as excitation and 535 nm as emission wavelength. The 
cells were then incubated with the dye C11-BODIPY (Invitrogen) at 37 °C for 30 min. After an additional wash in 
PBS, the cells were treated with H2O2 150 µM and incubated for 30 min. The ﬂuorescence of the samples was thus 
measured using the instrument EnVision (PerkinElmer), and from each measure the cell auto-ﬂuorescence value was 
subtracted. The values obtained from stressed cells (with the pre-treatment with the compounds) were expressed as 
percentage to the stressed control (without compounds treatment), set as 100%. 
 
3.6.3 DNA Repair/Protection (COMET assay) 
The comet assay (single-cell gel electrophoresis) is a simple and sensitive technique for the detection of DNA 
damage at the level of the individual cell. The term "comet" refers to the pattern of DNA migration through the 
electrophoresis gel, which often resembles a comet, where the length of the comet tail (damaged DNA) relative to 
the head (nuclear region), reflects the number of DNA breaks. 
Fibroblasts NIH3T3, maintained in DMEM with 10% FCS under 5% CO2 at 37 °C, were plated at density of 1.5 x 
105 per well in 6 well plates, for 6 hours. After 18 h of incubation with test compounds, cells were treated with H2O2 
175 µM for 2.5 h and detached from the plate using 1 ml/well of cell dissociation non-enzymatic solution. Cells 
were transferred to Eppi-tubes, spun at 1500 rpm and washed once with PBS. The cell pellet was resuspended in 20 
µl of PBS and 80 µl of Low Melting point Agarose (LPMA) was added to each tube, and the solution immediately 
dropped onto a Normal Melting Agarose (NMA) pre-coated slide. Coverslip slides were placed on the top, without 
squeezing the cells. Then, coverslips were gently slid off without scraping the agarose layer containing the cells. 
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tank, filled with an alcaline buffer for 10 min to allow DNA unwinding and the expression of alkali-labile damage, 
and then power supply was turned on to 24 volts. Slides were electrophoresed for 20 min and at the end placed in 
cold Neutralization buffer for at least 10 min. After drying the slides, cells were stained with a 10 µg/ml solution of 
ethidium bromide, covered with a coverslip and scored at a fluorescence microscope. 
 
3.6.4 Hydration and moisturizing activity 
3.6.4.1 Semi-quantitative Reverse Transcriptase/Polymerase Chain Reaction (RT/PCR) 
1.5 x 105 HaCaT cells, maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 10% FBS under 5% CO2 
at 37 °C, were seeded in 6 well plates and grown for 6 h to let them attach to the bottom of the well. The cells were 
then incubated for 6 hours with the test compounds, and then collected for total RNA extraction. Total RNA was 
extracted with the GenElute Mammalian Total RNA Purification Kit (SIGMA-ALDRICH, Milan, Italy) according 
to the manufacture’s instructions and treated with DNAse I at 37 °C for 30 min to eliminate any contaminating 
genomic DNA. The first strand cDNA was synthesized from 1-2 µg using the RevertAid™ First Strand cDNA 
Synthesis Kit (Fermentas). RT-PCR was performed using gene specific primers and the QuantumRNATM 18S 
internal standard (Ambion) according to manufacturer’s instructions. The QuantumRNATM kit contained primers to 
amplify 18S rRNA along with competimers that reduced the amplified 18S rRNA product within the range to allow 
it to be used as endogenous standard.  
The PCR products obtained were loaded on 1.5% agarose gel, and the amplification bands were visualized and 
quantified with the Geliance 200 Imaging system (Perkin Elmer). The amplification band corresponding to the gene 
analyzed was normalized to the amplification band corresponding to the 18S. The values obtained were finally 
converted into percentage values by considering the measure of the untreated controls as 100%.  
 
Gene Specific Primers used: 
AQP3-Fw: 5’ GATCAAGCTGCCCATCTA 3’  
AQP3-Rv: 5’ TGGGCCAGCTTCACATTCT 3’ 
HAS3-Fw: 5’ AGCCTATGTGACGGGCTA 3’ 
HAS3-Rv: 5’ TCCCCACTTCTGCATGATG 3’ 
FLG-Fw: 5’ AGAGCTGAAGGAACTTCTGG 3’ 
FLG-Rv: 5’ GTGTCATAGGCTTCATCC 3’ 
SMIT-Fw: 5’ ATGAGAGCTGTACTGGACAC 3’  
SMIT-Rv: 5’ GTCATGCCAATGAGCAGGAT 3’ 
 
3.6.4.2 Permeability assay 
The water permeability assay was set up using a well established method as described by Zelenina et al., 200273, 
200374, 200475. 
1.8 x 104 HaCaT cells, maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 10% FBS under 5% CO2 
at 37 °C, were seeded in 96 well plates and grown for 6 h to let them attach to the bottom of the well. The cells were 
then incubated with different Spirulina extracts or Retinoic acid 1 µM, used as positive control, for 18 h. 
The cells were loaded with 10 µM calcein-AM (calcein-acetoxymethyl ester, Santa-Cruz Biotechnology) for 1 h at 
37 °C in Hanks’ balanced salt solution (HBSS). Upon addition of calcein/acetoxymethyl ester, the dye enters the 
cells and becomes fluorescent on de-esterification. The poly-anionic nature of calcein renders its membrane 
impermeable, and thus it is retained within the cell under normal physiological conditions. After washing with PBS, 
the cells were alternatively stressed with sorbitol 500 mM and deionized H2O with cobalt chloride 1 mM, which 
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adherent cells was measured at 480 nm excitation and 535 nm emission by using a fluorescence multi-well plate 
reader (EnVision, Perkin Elmer). Fluorescence images were recorded after the stress and the relative fluorescence 
was quantified as percentage, considering the measurement of the stressed control as 100%. 
 
3.7 Statistical analysis 
The obtained results are average of three independent experiments each one conducted in triplicate. Data are 
presented as mean±SD for the different experiments while for the determination of differences, the student t-test 
GraphPad was used. Significant difference was set at p < 0.05.
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4. RESULTS AND DISCUSSION 
4.1 Samples preparation 
Arthrospira maxima was grown in open pond, showing a daily productivity of 7.4 ± 3.5 g m-2d-1 (Langellotti et al., 
submitted76). Frozen Spirulina was aseptically added to ultrapure water (30 g/L) and was whisked with Mixer 
(Continental Equipment Super mixer and tilting, Asal 715) for 15 min. In order to obtain various samples, this initial 
preparation was divided into 3 batches. 
1) One was pre-autoclaved (121 °C, 15 min) in order to decontaminate the biomass from indigenous bacteria. This 
sample was denoted as SEA (Spirulina Extract Autoclaved). An aliquot of autoclaved Spirulina was further 
incubated at 37 °C for 48 h with a probiotic mix Yovis®. The code of this preparation was SEA-Y (Spirulina Extract 
Autoclaved and Fermented with Yovis®), and in the bioassays its activity was compared with that of its control 
SEA. 2) A second batch of fresh biomass was set to undergo natural fermentation without addition of inoculum. 
Biomass contains some native bacteria that provoke fermentation in culture conditions. The fermentation took place 
at 37 °C for 24 hours. This sample was denoted as SEA-F (Spirulina Extract Auto-Fermented) and it was compared 
to its control Spirulinal Extract (SE), the untreated sample. 3) A third batch of fresh biomass was digested by 
carbohydrases and proteases, and it was denoted as SED (Spirulina Extract Digested). Also for this sample, the 
control was always Spirulina Extract (SE). 
After treatments, all the samples were centrifuged at 4000 g for 15 min. Supernatants (crude aqueous extracts) were 
collected and lyophilized (Modulyo, 2000). The experiments are summarized in the flowchart of figure 5. The code 
of each sample in the experimental plan is reported in table 6. 
All samples were filtered to 0.45 µm in order to obtain extracts without bacterial contamination necessary for further 

























Table 6: Samples description and codes. 
  
CODE Sample Description 
SE Spirulina extract  
SEA-F 
SED 
Spirulina auto-fermented extract 
Spirulina enzymatically digested extract 
SEA Spirulina extract after autoclaving (control of SEA-Y) 
Yovis® Commercial probiotic starter culture 
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4.2 Molecular mass of Spirulina extracts 
In order to analyse the level of protein degradation of the obtained different fermented products, we performed a 
SDS-page by running the samples reported in table 6, in a 15% polyacrylamide gel and staining the protein bands by 
Coomassie blue. The band corresponding to the C-phycocyanin (17 kD), visible in the total extract in lane 2, was 
still visible in the lane 3 of the sample subjected to auto-fermentation, indicating that this type of process did not 
produce any degradation of the protein (Figure 7). On the opposite, the enzymatic digestion (lane 4), the autoclaving 
process (lane 5) and the autoclaving plus fermentation (lane 6) produced protein degradation, thus no clear protein 
band corresponding to the C-phycocyanin was detectable. This indicated that the C-phycocyanin, which represented 
almost 15% of the whole weight of the microalga, had been digested into smaller peptides by the sterilization 
















Figure 7. SDS-PAGE analysis of Spirulina extracts. Lane 1: Marker; lane 2: Spirulina total extract; lane 3: Spirulina 
after autofermenting process; lane 4: Spirulina derived by enzymatic digestion; lane 5: Spirulina after autoclaving 
process; lane 6: Autoclaved Spirulina after fermentation by Yovis® (10 µg of total proteins of each lane). 
 
 
4.3 Spirulina citotoxicity 
The Spirulina extracts, prepared as described in Materials and Methods and showed in table 6, were first tested in 
the MTT assay on NIH3T3 fibroblasts and HaCaT keratinocytes, to define the right concentrations of use in the 
following experiments and to determine the maximum non-cytotoxic concentration. The results showed that all the 
concentrations lower than 0.1 g/L did not affect the viability of the cells (Figure 8), and for all of them the DL50 
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Figure 8: MTT assay. Fibroblasts were treated for 48 h with different concentrations of different Spirulina extracts. 
After treatments, the percentage of vital cells was measured for each sample using the MTT dye. The values are 
means of three independent measures obtained from one representative experiment. 
 
 
4.4 Antioxidant effect of Spirulina derivatives 
According to the literature, Spirulina, such as other microalgae, is considered as a rich source of proteins with 
antioxidant properties (Herrero et al., 200577; Chidambara Murthy et al., 200578; Tannin-Spitz et al., 200579). To 
evaluate the capacity of Spirulina extracts to neutralize the dangerous free radicals in the cells, we conducted a 
series of experiments to measure the total antioxidant power of the mixture both in vitro and in cultured skin cells. 
Spirulina is well-known to have antioxidant properties, which are attributed to molecules such as phycocyanin, β-
carotene, tocopherol, γ-linoleic acid and phenolic compounds (Chopra and Bishnoi, 200880). 
Wu et al. (200552) reported that Spirulina extract has a higher antioxidant activity than the microalga Chlorella, 
because of its higher content of phenolic compounds. Thus, in our experiments we compared the fermented extracts 
of Spirulina with the extracts of total biomass in order to demonstrate the best antioxidant efficacy.  
As in vitro assay we performed an ORAC (Oxygen Radical Absorbance Capacity), where the different dilutions of 
the samples were mixed with fluorescein and the reaction started by the addition of the oxidant AAPH. The value of 
reducing capacity was of 360 µmol TE/g for SE and 346 µmol TE/g for SEA. After the auto-fermentation of SE or 
fermentation by Yovis® of SEA, the ORAC values changed from 360 and 346 into 332 or 340 µmol TE/g, 
respectively. Thus, both the autoclaving process and the fermentation by Yovis® had no significant effect on the 
antioxidant power. Differently, the ORAC value of SED changed from 360 µmol TE/g into 380 µmol TE/g, 
indicating that the digested samples had a higher antioxidant capacity compared to the non-digested ones. This 
meant that probably during the digestion process the main components, proteins, vitamins and antioxidants 
molecules, were transformed or hydrolysed into simpler compounds with higher antioxidant power. Therefore, these 
ORAC values, ranging from 332 to 380 µmol TE/g, were higher than those reported for other antioxidant rich algal 
extracts (Li et al., 200181; Plaza et al., 201082). 
Although the ORAC assay measures the reducing potential of the test materials, however it cannot provide any 
information on the antioxidant capacity in living cells. On the other hand, measuring the amount of Reactive 
Oxygen Species (ROS) present in the cell membranes by the ROS assay gives important clues about the real 
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ROS are also a physiological products formed during aerobic life as a result of the metabolism of oxygen, thus, they 
can also damage the cellular membrane or intracellular molecules (especially DNA) if not efficiently removed by 
the antioxidant defence mechanism of the cell (Cooke et al., 201083). 
To evaluate the capacity of Spirulina extracts to scavenge the ROS produced on the cell membrane after oxidative 
stress, we treated mammalian immortalized keratinocytes (HaCaT) with two different concentrations of the extracts. 
The results indicated that the amount of ROS produced in the cells after treatment with 450 µM H2O2 was 
significantly reduced by Spirulina extracts. The extracts SEA-F and SEA-Y at both the concentrations and SEA at 
0.1 g/L inhibited ROS formation, which was comparable to the effect produced by Tocopherol, a compound known 
for its strong antioxidant power on the cells. SE showed a modest inhibitory effect on ROS production (17%) when 
used at 0.02 g/L. The results of the ROS assay indicated that the extracts subjected to the autoclaving process had a 
higher protecting capacity against ROS compared to the untreated ones, probably because the heating resulted in a 
change of the nature and the size of the compounds originally present in the extract SE. Moreover, fermentation by 
Yovis® restored the antioxidant capacity of SEA by 40% at 0.02 g/L. 
The auto-fermenting process enhanced the capacity of Spirulina to protect the cell membranes against ROS 
production. At both concentrations of 0.1 g/L and 0.02 g/L, the extracts reduced the amount of ROS, induced by 
H2O2 treatment, by about 33% (p<0.05). Finally, when the cells were pre-treated with SED, at both the 
concentrations, the keratinocytes were protected and the ROS production was decreased by about 25%. These 
results suggested that also the enzymatic digestion improved the antioxidant capacity of the Spirulina extracts, even 
if in a smaller extend than the auto-fermentation and Yovis® fermentation processes. 
The attenuation of the H2O2 induced stress obtained after treatment with Spirulina extracts could be explained both 
by a direct interaction with the stressing agent (the compound mixture may interact with H2O2 neutralizing its 
oxidizing action on the cellular components) and by an activation of the defence response mechanism to stress by 
triggering specific signaling pathways in the cells. 
 
 
Figure 9. Lipid peroxidation in HaCaT cells after incubation for 2.5 hours with the Spirulina extracts and 
Tocopherol. Data are presented as percentage to the stressed control without treatment, arbitrarily set as 100%. 
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amount of nuclear DNA damage after hydrogen peroxide treatment by performing a Comet assay. The cells were 
first treated with different Spirulina extracts for 18 hours and then stressed with H2O2 175 µM. This assay allowed 
to evaluate the amount of DNA damage by measuring the length of a fluorescent nuclear “comet tail”, which was 
proportionally related to the entity of the DNA damage produced in the cell nuclei. 
The comet tail length was significantly reduced (p<0.05) from 30 to 40% in the cells pre-treated with SEA-F and 
SEA underlying that the DNA protective capacity of the extracts was preserved during the sterilization process. On 
the other hand, the enzymatically digested Spirulina (SED) did not show any protective effect on DNA from H2O2 
induced damage. As positive control of the assay, an extract derived from Dolichos biflorus cell cultures, already 


















Figure 10. Comet assay. The pictures show the damages to cell nuclear DNA produced by treatment with different 
extracts of Spirulina compared to an untreated control. Cells in the panel D were previously incubated with SEA for 
18 h. Each value was calculated in microns as average of 100 different measures, and then expressed as percentage 
to the untreated control, arbitrarily set as 100%. 
 
 
4.5 Hydration and moisturizing capacity 
Besides the oxidative stress protection, there is much interest in studying the capacity of compounds and extracts to 
protect human cells from de-hydration and osmotic stress, which may alter significantly the cell functionality and 
homeostasis, in particularly in the skin. 
Skin is the outer tissue covering of the body, thus it represents an effective barrier between the organism and the 
environment, which is indispensable for the prevention of the invasion of microorganisms, chemical compounds and 
allergens, and the maintenance of moisture levels of the skin. Skin is composed of three layers: the epidermis, 
dermis, and hypodermis. The epidermis is a stratified squamous, keratinized epithelium composed of the stratum 
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Figure 11. The most superficial layer of the skin is the epidermis. It is divided in five layers: stratum basale, stratum 




A decrease in SC water content is found in a number of common skin diseases, such as AD, eczema, psoriasis, 
senile xerosis, and hereditary ichthyosis (Hara et al., 200286). Dehydration is also one of the major characteristics of 
aged skin. 
To measure the capacity of the Spirulina extracts to protect cells from dehydration, we analyzed the gene expression 
of proteins specifically involved in the maintenance of water balance in human skin cells, such as Aquaporin-3 
(AQP3), Hyaluronan Synthase-3 (HAS3), and Filaggrin (FLG) (Fig. 12). AQP3 is an integral membrane channel in 
epidermal keratinocytes and mediates water and glycerol movement into and out of the skin. HAS3 is the enzyme 
that polymerizes low molecular weight hyaluronic acid (HA) in keratinocytes (Ijuin et al., 200187). HA plays a 
predominant role in the epidermis and in the dermis, enabling these tissues to maintain their hydration level thanks 
to its high water retention ability. HA holds the water together and keeps body smooth, moist and lubricated. The 
level of hyaluronic acid decreases with age and this is intimately linked with dehydration, loss of elasticity and the 
appearance of wrinkles (Ghersetich et al., 199488). This leads to an increase in the hyaluronic acid content of the 
dermis and the epidermis, improving the structure of the extracellular matrix, and helping to ensure skin flexibility 





RESULTS AND DISCUSSION 
FLG is a filament-associated protein that binds to keratin fibres in epidermal cells and is important for the skin’s 
waterproof properties. 
SE and SEA-F increased gene expression of AQP3 by 28% and 19% at 0.1g/L, respectively, while SED increased 
AQP3 gene expression by 28% only at the concentration 0.02 g/L. Moreover, SED induced HAS3 gene expression 
by 22% and 46% at 0.1 g/L and 0.02 g/L, respectively. 
Also SEA induced gene expression of AQP3 by 29% at both the concentrations. The effect produced by the lactic 
acid fermented samples was even higher: they induced AQP3 and HAS3 gene expression by 80% and 29% at 0.1 
g/L, respectively, showing a higher hydrating capacity compared to the autoclaved Spirulina (SEA) used at the same 
dose. Retinoic acid, a vitamin A derivative, known for its capacity to promote cell hydration, was used as positive 
control in the experiments (Cao et al., 200889; Bellemère et al., 200890; Sayo et al., 201391). 
Water is also retained in the cells of the epidermis thanks to the NMF (natural moisturizing factor), which consists 
of molecules present in the corneocyte cells of the stratum corneum. Thanks to these substances, the skin is able to 
fix water in the epidermis and to maintain the hydration level necessary for its proper functioning. The main part of 
the NMF is composed by small peptides or amino acids derived from the degradation of filaggrin. FLG is expressed 
as a profilaggrin of >400kDa in humans, which is a major component of keratohyalin granules in the stratum 
granulosum of the epidermis (Dale et al., 198592; Presland et al., 200593). When keratinocytes move upward from 
the stratum basale to the stratum corneum, they dramatically change their shapes becoming dead cells without 
intracellular organelles and containing keratin bundles and lipids to constitute the stratum corneum (Candi et al., 
200594). At the stratum granulosum-to-stratum corneum transition, each filaggrin filament is processed by certain 
proteases to generate the filaggrin monomer. The resulting filaggrin monomers are joined to keratin cytoskeleton to 
form microfibrils (Dale et al., 197895). Keratin-bound filaggrin is degraded into amino acids, which constitute a part 
of the natural moisturizing factor in the upper stratum corneum (Tarcsa et al., 199696; Mechin et al., 200597; Nachat 
et al., 200598). In this respect, a number of compounds that naturally occur in many medicinal herbs and plants, such 
as oleanolic acid, ursolic acid, and pentacyclic triterpenoids, have been shown to improve skin barrier function by 
increasing FLG expression (Lim et al., 200799). On the basis of the obtained results regarding the AQP3 and HAS3 
expression, we investigated the capacity of Spirulina extracts to induce another important gene involved in cell 
hydration, filaggrin. More specifically, FLG has a key role in keeping the skin moisturized, guaranteeing the proper 
corneocyte cohesion and avoiding excessive water loss through the upper epidermal layers. Moreover, FLG is an 
important source of NMF upon degradation, further contributing to the maintenance of the necessary water retention 
capacity of the skin and its osmotic proprieties (Tarcsa et al, 199696; Mechin et al, 200597; Nachat et al, 200598). 
In accordance with the results described above, both SEA and SEA-Y induced FLG expression by 75% and by 59% 
respectively, at the concentration of 0.1 g/L, an effect even higher that the positive control CellPulse, an hydro-
soluble extract derived from Coffea bengalensis cell cultures (Bimonte et al., 2011100). 
The higher activity of the samples derived from auto-fermenting process, digestion by enzymes or fermentation by 
Yovis® compared to the control Spirulina extract or Spirulina autoclaved, could be explained by the effect of the 
autoclaving, followed by fermentation process, on the proteins contained in the Spirulina lysate, which produce 
small size peptides and molecules capable of passing through the plasma membrane more easily and thus 














RESULTS AND DISCUSSION 
 
Figure 12. RT-PCR analysis of gene expression in HaCaT cells treated with two different concentrations of 
Spirulina extracts. Cell samples were treated with the extracts indicated for 6 h. The pictures show the amplification 
bands of the genes AQP3, HAS3 and FLG. The amplified bands were quantified using Geliance 200 Imaging 
software and the values obtained normalized to the internal standard 18S. All the values were reported in the graphs 
above the pictures and expressed as percentage to the control, set as 100%.  
 
 
4.6 Protection from osmotic stress 
Another activity which is particularly requested for ingredients specifically developed for skin care applications is 
the capacity to protect cells against osmotic stress, due to either hyper or hypotonic pressure. 
Regulation of cell and total body water content is an essential homeostatic function. The skin of animals and humans 
is challenged by exposure to an environment that varies in humidity from 0 to 100%. Less than 100% relative 
humidity can produce significant dehydration or osmotic stress on the epidermis, which then must respond and 
protect the organism from water loss. A decrease in skin water content is found in a number of common skin 
diseases, such as AD, eczema, psoriasis, senile xerosis, and hereditary ichthyosis (Hara et al., 200286). The major 
function of the epidermis is to provide protection from this loss of water and dehydration (Nolte et al., 2011101). 
Cells adapt to the hypertonicity by a variety of biophysical (cell shrinkage and a subsequent regulatory volume 
increase), biochemical (opening/closing of ion channels; increased transport or synthesis of compatible osmolytes; 
enzyme activation) and genetic (induction of selected gene expression) mechanisms (Burg and Garcia-Perez, 
1992102; Burg, 1995103). 
In order to keep a well-hydrated and functional skin, it is necessary that all the small compounds, responsible for 
osmotic balance and moisturization, are correctly distributed throughout the upper skin layers. In particular, water is 
retained in the cells of the epidermis thanks to the NMF, which consists of molecules present in the corneocyte cells 
of the stratum corneum. The main part of the NMF is composed by small peptides or amino acids derived from the 
degradation of FLG, as already mentioned. Functionally related to FLG, SMIT is a gene involved in the protection 
from osmotic stress. SMIT-1 is the sodium-dependent myo-inositol cotransporter-1, which utilizes the 
electrochemical gradient of Na+ across the plasma membrane to import myo-inositol (MI), with two Na+ coupled to 
each molecule of MI (Hager et al., 1995104). Myo-inositol is a crucial constituent of living cells. It serves as an 
organic osmolyte, and its level increases when cells are under a hypertonic environment (Garcia and Burg, 1991105, 





RESULTS AND DISCUSSION 
Phosphorylation of MI generates a number of different phosphatidylinositol phosphates (PIPs) derivatives with 
important physiological functions, such as cell survival, growth, vesicular trafficking, and glucose homeostasis 
(Katso et al., 2001107). 
To evaluate the ability of Spirulina derived extracts to protect the keratinocytes from osmotic stress, the cells were 
treated for 6 h with different Spirulina extracts. SEA-Y induced SMIT expression by 59% (p<0.01) and 31% 
(p<0.05) at 0.1 g/L and 0.02 g/L, respectively, while SED increased SMIT expression by 21% (p<0.01) at 0.1 g/L 
(Fig. 13). In agreement with the previous results, both the autoclaving process and lactic bacteria fermentation 
produced the most evident effect on the capacity of the cells to overcome osmotic stress conditions, most likely due 
to the formation of osmolites able to protect better the cell membrane from stressing agents that altered the correct 
water homeostasis in the cells. 
 
Figure 13. RT-PCR analysis of SMIT expression in HaCaT cells treated with two different Spirulina extracts. The 
amplified bands were quantified using Geliance 200 Imaging software and the values obtained normalized to the 
internal standard 18S. All the values were reported as percentage to the control, set as 100%. 
 
 
4.7 Permeability assay 
The capacity of extracts or compounds to protect the cells against osmotic stress can be also evaluated by measuring 
how cultured cells respond to hypo or hyper-osmotic environments by swelling or shrinking, respectively. In order 
to confirm the gene expression results, we set up a permeability assay, based on protocols described by Zelenina et 
al., 200273, 200374, 200475, adapted to our cell system. 
The keratinocytes HaCaT were pretreated with or without the different Spirulina extracts and then exposed to hyper-
osmotic stress (sorbitol 500 mM) or hypo-osmotic stress (deionized water). The application of the stress produced a 
significant alteration of membrane permeability, measured by changes in the fluorescence emission. The calcein, 
contained in the cells, was released after the membrane damage, resulting in the decrease of the fluorescent signal. 
The Spirulina extracts inhibited osmotic stress damages in the cells by slowing down either the swelling or the 
shrinking process, caused by sorbitol or distilled water, respectively. In figure 14, it is shown how the hyperosmotic 
shock applied to the cells could be partially recovered by the treatment with SED, SEA and SEA-Y, similarly to 
retinoic acid. For the hypo-osmotic stress, caused by distilled water, the recovery was only detectable for the 





RESULTS AND DISCUSSION 
Consistent with the gene expression analysis, the results of this assay supported the role of the SED, SEA and SEA-










Figure 14. HaCat cells were incubated with different Spirulina extracts or Retinoic acid 1 µM, used as positive 
control, for 18 h. Cell water permeability was analyzed by the method described above and shown in (A). The 
relative fluorescence intensity was reported as percentage to the control, set as 100%. In the graph B was reported 
the water permeability in presence of hyper osmotic stress (D-sorbitol 500mM). The graph C reported the water 

















Microalgae have been exploited for millennia as sources of several bioactive ingredients. Currently, they have 
several applications from human and animal nutrition, pharmaceutics to cosmetics, both as extracts and purified 
molecules (e.g., fatty acids, pigments, stable isotope biochemical). In table 5 is reported a list of the main microalga 
species cultivated in different areas of the world and their main application field. However, microalgae are still not a 





Table 5. Present state of microalgal production (Pulz and Gross, 2004108). 
 
 
In the research study that I conducted during my PhD course, the microalga A. maxima was selected due to its ability 
to grow more easily both in the laboratory and in large-scale facilities, and for its features of being a potential 
interesting source of proteins and therapeutic compounds. In order to make the extracts obtained from Spirulina 
even more valuable in terms of industrial applicative output, different types of fermentation processes were 
conducted and the derived products analyzed for their efficacy in cellular based tests. The assumption of this 
research was based on several studies that demonstrated the advantages of having small peptides and processed 
macromolecules with higher biological activity than their bigger counterparts, higher specificity (minimal unspecific 
binding), and often lower toxicity due to minimal accumulation in tissues (Marx, 2005109; Ayoub and Scheidegger, 
2006110). 
Spirulina lysate showed to be a perfect candidate for this type of study, since this microalga was extremely rich in 
functional macromolecules (proteins, polysaccharides and essential fatty acids) that could be easily processed using 
fermentation (Estrada et al., 2001111). 
The C-phycocyanin, the most represented protein in Spirulina hydro-lysate, was a good molecular marker to follow 
the different steps of the fermentation process, each associated with a different degree of macromolecule 
degradation, as confirmed by the SDS-PAGE analysis conducted in the unfermented samples as well in the 
fermented ones. Three types of fermentation processes were compared in this study, one based on the use of 
indigenous bacteria (auto-fermentation), those developed spontaneously in the lysate; the second based on the use of 
the mix Yovis® (Sigma-Tau), added after a sterilization procedure of the lysate; and the third performed by 
employing enzymes (carbohydrase and Alcalase), thus without using any microorganism. 
The results of the study underlined that the Spirulina lysates treated either by biological or enzymatic fermentation 
were significantly more efficient than the untreated samples in protecting cell membrane from lipid peroxidation, 
even though their total antioxidant power, measured by ORAC assay, was slightly lower in the sample fermented by 
Yovis®. This can be explained with the consideration that during the fermentation process many redox reactions 
occur and many phenolic compounds and macromolecules may partially loose their capacity to transfer electrons. 
This phenomenon does not necessarily means that these compounds loose their capacity to protect the cells against 
ROS formation, which is totally dependent on the ability of these molecules to interact with the cell constituents and 
to penetrate the cells through the membrane. Based on this assumption, smaller compounds, that result from the 






action in the cell. The effect of protection on nuclear DNA was also detectable in some of the treatments with the 
fermented samples, indicating that fermented products (auto-fermented and fermented by Yovis®) were able to 
penetrate cell membrane and prevent DNA damage by oxidative stress. 
Gene expression analysis, analogously to the previous studies, revealed that in cultured keratinocytes the fermented 
samples were able to induce the genes involved in hydration AQP3, FLG and HAS3, suggesting also a role as 
signaling complexes, capable to trigger signal transduction pathways, possibly through the activation of receptors 
either outside or inside the cells. Surprisingly, the samples that were the most active in inducing the expression of 
hydration genes were those treated enzymatically. SED showed the strongest effect at the dose of 0.02 g/L for all 
tested genes. The induction of these genes, involved in the hydration process indicates an increase of the capacity of 
the cells to retain water, and guarantee a correct water balance homeostasis within the tissues. This is a very 
important characteristic claimed by many cosmetic products, as water dehydration is one of the main problem 
related to aged skin. Moreover, in the SMIT gene expression analysis, related to the osmotic stress protection, and in 
the membrane permeability determination, the enzymatically digested sample, SED, at concentration of 0.1 g/L, 
showed again the highest protection activity, confirming the potential role of this type of product in enhancing both 
a correct water distribution and osmolite balance in the upper skin layers. 
There are other examples in literature of the development of potential industrial products derived from 
biotechnological processing. A fermentation of the alga Gracilaria tikvahiae is an example of a cosmetic active 
ingredient involved in stimulating proteasome activity in skin cells (Chavan et al., 2013112). Indonesian tempeh and 
Oriental soy sauce are well known examples of indigenous fermented foods that have been industrialized and 
marketed globally (Hachmeister and Fung 1993113; Sugiyama 1984114). Another example of cosmetic application of 
a fermented algae is represented by peptides or protein hydrolysates derived from Porphyra spp. and wakame 
seaweeds under appropriate conditions (Hagino and Masanobu, 200351). 
In conclusion, the products derived from Spirulina fermentation can find application in both the cosmetic field, as 
hydrating and moisturizing agents for skin care, and in nutraceuticals, as food supplements able to increase the 
natural defense response of the cells and to guarantee a more efficient balance of nutrients in the body. 
In particular, Arterra Bioscience srl, the collaborating company of my PhD course, has already shown considerable 
interest to include one or more products, deriving either from Spirulina microbial fermentation or enzymatic 
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MI2014A 000186 Composizioni cosmetiche comprendenti 
estratti derivati dalla microalga Galdieria 
sulphuraria, particolarmente indicate per ridurre gli 
effetti dannosi causati dall’acne.  
M. Bimonte, A. De Lucia, A. Tito, A. Carola, F. Apone, 
G. Colucci, V. Fogliano, S. Buono, Martello A., 
Langellotti L., Pollio A., Pinto G. 
------- 
La presente invenzione si riferisce all’uso in 
campo cosmetico di estratti cellulari derivati dalla 
microalga appartenente al genere Galdieria, 
preferibilmente alla specie G. sulphuraria e alle 
relative composizioni dermocosmetiche comprendenti 
detti estratti aventi effetti seboregolatori, 
antibatterici e di stimolazione del sistema di difesa 
della pelle, utili per alleviare gli effetti dannosi 
causati dall’acne sulla pelle. L’invenzione concerne 
ulteriormente un metodo per ottenere i suddetti 
estratti. 
Come è noto, la pelle svolge funzioni vitali nel 
nostro organismo, quali la regolazione della 
temperatura corporea, la  percezione sensoriale, 
l'azione protettiva e di difesa contro patogeni e 
radiazioni UV, che possono venir compromesse da 
numerose patologie. 
Una delle funzioni più importanti della pelle è 
proprio quella protettiva, che è assicurata dalla 
presenza del sebo, una miscela complessa di lipidi, 
trigliceridi, cere ed esteri del colesterolo, steroli, 
squalene, paraffina ed acidi grassi liberi (insaturi e 
saturi). Il sebo è fondamentale per la formazione del 
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film idrolipidico che ricopre la pelle ed il cuoio 
capelluto, in quanto protegge la superficie cutanea 
dalle aggressioni chimiche (detergenti, solventi, 
inchiostri, ecc.) e batteriche, lubrifica ed 
impermeabilizza la superficie, permettendo alla pelle 
di mantenere un giusto livello di idratazione. Il sebo 
è prodotto da piccoli organi specializzati, le 
ghiandole sebacee, che sono localizzate in tutta la 
superficie della pelle, ad eccezione dei palmi delle 
mani e delle piante dei piedi. Le ghiandole sebacee non 
hanno una distribuzione omogenea nella pelle, ma si 
fanno molto più abbondanti e produttive in aree cutanee 
particolari, come quelle del viso e del cuoio 
capelluto, dove la funzione protettiva è ancora più 
importante. Le ghiandole sebacee sono generalmente 
associate ad un follicolo pilifero ed insieme ad esso 
formano l'unità pilo-sebacea. Una corretta regolazione 
dell’attività della ghiandola sebacea e di conseguenza 
della produzione di sebo, è quindi estremamente 
importante per mantenere una pelle sana e meno soggetta 
a patologie.  
L'attività della ghiandola sebacea è influenzata 
da numerosi fattori, tra questi i più importanti sono 
l’età dell’individuo ed il livello di un ormone 
androgeno, il testosterone. Infatti la massiccia 
attivazione delle ghiandole sebacee si ha soprattutto 
in età puberale, quando è più intensa la produzione del 
testosterone. La concentrazione del testosterone, 
ormone tipico dell'uomo ma presente in minori quantità 
anche nella donna, influenza quindi in modo 
determinante la produzione di sebo, in quanto proprio a 
Barzanò e Zanardo Milano S.p.A. 
 53 
livello della ghiandola sebacea esso viene convertito 
dall’enzima 5-α reduttasi in diidrotestorone, un 
derivato che attiva la biosintesi del sebo. Un’elevata 
concentrazione di testosterone, e quindi di 
diidrotestorone, porta ad una eccessiva produzione di 
sebo, definita seborrea, che conferisce alla pelle un 
aspetto lucido ed untuoso ed è spesso il fattore 
scatenante di una patologia più grave: l'acne. Proprio 
per questo motivo è fondamentale per l’organismo 
garantire sempre una giusta produzione di sebo per 
avere una pelle sana e funzionale. 
L'acne è un processo infiammatorio caratterizzato 
da lesioni del follicolo pilosebaceo. Essa insorge in 
soggetti in età giovanile, di regola nel periodo 
puberale, in quelle regioni del corpo più ricche di 
ghiandole sebacee, come viso e torace. Il processo 
infiammatorio dell'acne si origina da un eccessivo 
accumulo di sebo nella ghiandola sebacea dei follicoli 
piliferi, il sebo prodotto rappresenta il terreno di 
coltura per i batteri, quali Propionibacterium acnes e 
Staphylococcus epidermidis, che abitualmente 
colonizzano il follicolo pilifero. In condizioni 
normali, quando il sebo fluisce liberamente fuori dai 
pori, le popolazioni batteriche si mantengono a livelli 
bassi, ma un'eccessiva produzione di sebo ed un suo 
eccessivo accumulo nella ghiandola sebacea porta ad un 
proliferare incontrollato di batteri. 
I batteri proliferano e producono enzimi 
proteolitici in grado di ledere la parete del follicolo 
pilifero e riversare il contenuto della ghiandola 
sebacea nel derma sottostante, stimolando lo scatenarsi 
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di una reazione infiammatoria (Pawin et al., 2004). 
L’organismo umano ha sviluppato nel corso 
dell’evoluzione dei meccanismi di difesa contro 
l’attacco di microrganismi: tali meccanismi comprendono 
una prima risposta immunitaria aspecifica (o immunità 
innata) ed una seconda risposta specifica (o immunità 
acquisita). L’immunità innata è la prima linea di 
difesa per evitare l’ingresso ed il proliferare di 
agenti patogeni nell’organismo e per sconfiggerne 
l'eventuale azione patogena.  
L'immunità acquisita è invece la seconda linea nella 
difesa da agenti patogeni che agisce nel momento in cui 
l'immunità innata non riesce a distruggere l'agente. 
Le β-defensine, piccoli peptidi cationici, sono 
tra i maggiori componenti dell’immunità innata; esse 
presentano una spiccata attività antimicrobica, 
antivirale ed antimicotica. La loro particolare natura 
cationica gli permette di distruggere la membrana 
batterica, carica negativamente, legandosi ad essa, e 
di lasciare intatte le membrane delle cellule umane, 
che hanno carica neutrale. Inoltre le β−defensine 
stimolano la risposta specifica richiamando le cellule 
del sistema immunitario, quali  macrofagi e neutrofili, 
e promuovono il processo di rimarginazione delle 
ferite. Nei pazienti affetti da acne, l’espressione 
della β-defensine 2 (hBD-2) risulta aumentata nelle 
ghiandole sebacee (Chronnell et al., 2001), dove 
verosimilmente esse esplicano un ruolo importante nel 
proteggere dall’invasione microbica.  
L'acne, essendo caratterizzata dalla formazione di 
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comedoni, papule, pustole e talvolta di noduli e 
cicatrici, è molto spesso associata a disagi di tipo 
estetico e di carattere sociale, e questo spiega 
l’elevata attenzione che la cosmetica e la dermatologia 
hanno dedicato alla cura di questa patologia. 
Ad oggi, sono utilizzati diversi farmaci per il 
trattamento dell’acne, anche se ognuno di questi sembra 
agire su di uno solo degli eventi che portano allo 
scatenarsi dell'acne; inoltre alcuni di questi farmaci 
presentano delle controindicazioni. 
Tra questi l’isotretinoina, un derivato della 
vitamina A che inibisce la produzione di sebo. Tuttavia 
questo composto presenta numerose controindicazioni ed 
un elevato rischio teratogeno, pertanto è fortemente 
sconsigliato il suo uso nelle donne in gravidanza o 
addirittura in quelle che non hanno ancora avuto figli.  
Anche gli antibiotici, quali tetraciclina, 
eritromicina e la nadifloxacina, sono utilizzati per la 
cura dell'acne in quanto inibiscono la crescita dei 
batteri nella ghiandola sebacea, ma il principale 
limite nell'impiego di questi è l'insorgenza della 
resistenza agli antibiotici da parte dei batteri 
stessi.  
Sulla base di quanto sopra esposto appare evidente 
l’esigenza di disporre di nuovi composti in grado di 
contrastare l'insorgenza dell’acne, che siano al tempo 
stesso efficaci e sicuri, e che siano capaci di agire 
su più di uno degli eventi che portano allo scatenarsi 
della patologia.  
E’ noto nell’arte che le microalghe sono dotate di 
spiccate proprietà farmacologiche e terapeutiche grazie 
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alle numerose molecole attive in esse contenute: 
vitamine, aminoacidi, fitocolloidi, polisaccaridi, 
carotenoidi, ecc. 
Negli ultimi anni l’utilizzo degli estratti 
ottenuti da microalghe è aumentato molto in prodotti 
cosmetici, con applicazioni che vanno dalla cura del 
viso, a quella del corpo e capelli.  
In particolare, la microalga Galdieria sulphuraria 
rappresenta una specie di particolare interesse per la 
sua straordinaria capacità di crescere in condizioni 
estreme, come ad esempio ambienti estremamente acidi e 
temperature elevate (Ott and Seckbach, 1994), e per la 
sua versatilità nella crescita, che rende detta alga 
capace di adattarsi ai cambiamenti ambientali 
(Oesterhelt et al. 2007). A tale proposito, la sua 
presenza all'interno del cratere del vulcano Solfatara, 
e in particolare nel sito di Pisciarelli, Agnano, 
Napoli, è stata documentata da diversi anni (Merola et 
al.1981): le temperature superiori ai 60°C e l’acidità 
(pH compresi tra 0 e 4) rendono questo ambiente idoneo 
alla crescita di pochissimi organismi, tra cui questa 
microalga rossa. La sua versatilità metabolica, dovuta 
alla capacità di produrre un vasto repertorio di enzimi 
metabolici, in parte ottenuti mediante un processo di 
trasferimento genico orizzontale (HGT) da batteri ed 
archea che convivono nello stesso ambiente (Schönknecht 
et al., 2013), rende questa microalga capace di 
adattarsi ai cambiamenti ambientali e di crescere sia 
alla luce, in autotrofia, sia al buio, in eterotrofia, 
in presenza di un’ampia gamma di substrati organici 
(Gross et al., 1998).  
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Tuttavia non esistono studi relativi all’utilizzo 
dell’estratto di questa specie di microalga come 
principio attivo, sfruttabile a livello cosmetico in 
formulazioni di diverso genere. 
Gli autori della presente invenzione hanno trovato 
che estratti cellulari derivati dalla microalga 
appartenente al genere Galdieria, preferibilmente alla 
specie G. sulphuraria, testati su cellule della pelle 
in coltura, si sono dimostrati in grado di: i) 
diminuire (inibire) l’attività dell’enzima 5α-
reduttasi; ii) inibire la crescita dei batteri; iii) 
indurre l’espressione delle β-defensine; iv) accelerare 
il processo di rimarginazione delle ferite. 
Le cellule di G. sulphuraria utilizzate nella 
presente invenzione sono state inizialmente raccolte 
nei pressi della solfatara di Pozzuoli da parte del 
gruppo del Dipartimento di Biologia, Orto Botanico, via 
Foria 223, 80139 – NAPOLI. 
Gli estratti cellulari derivati dalla microalga 
appartenente al genere Galdieria, preferibilmente alla 
specie G. sulphuraria, mostrano avere, quindi, delle 
spiccate proprietà per alleviare gli effetti dannosi 
della eccessiva produzione di sebo (iperseborrea) e 
dell’acne, grazie alle proprietà di seboregolazione, 
antibatteriche e di stimolazione del sistema di difesa 
della pelle. Costituisce pertanto un primo aspetto 
della presente invenzione un metodo per ottenere un 
estratto da cellule in coltura liquida della microalga 
Galdieria, preferibilmente della specie G. sulphuraria, 
comprendente le seguenti fasi a)-g): 
a) allestimento delle colture algali monospecifiche di 
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Galdieria, preferibilmente della specie G. sulphuraria, 
e crescita delle cellule in coltura liquida in un 
appropriato terreno di coltura;  
b) separazione delle cellule dal mezzo di crescita; 
c) omogeneizzazione delle cellule;  
d) centrifugazione dell'omogenato per isolare 
l'estratto idrosolubile, rappresentato dal 
sopranatante.  
La microalga Galdieria, preferibilmente della 
specie G. sulphuraria, può essere fatta crescere in 
autotrofia, eterotrofia o mixotrofia, in diversi tipi 
di terreni di coltura acidi: è sufficiente che i 
terreni contengano fonti organiche o inorganiche di 
azoto, fosforo, carbonio e zolfo, e abbiano un pH 
variabile da 0 a 5. L’intervallo della temperatura di 
crescita ottimale è compreso tra 20 °C e 55 °C, essendo 
una microalga che si adatta bene a diverse temperature. 
Secondo una forma di realizzazione preferita, la 
microalga Galdieria, preferibilmente della specie G. 
sulphuraria, è fatta crescere in eterotrofia ad una 
temperatura da 26 a 37 0C. 
Un terreno di coltura particolarmente preferito 
della fase a) comprende: 1,32 g/L di (NH4)2SO4, 0,6 g/L 
di K2HPO4, 0,1 g/L di NaCl, 0,3 g/L di MgSO4, 0,00996 
g/L di FeSO4, 0,02 g/L di CaCl2, 30g/L glucosio, 0,0199 
g/L di MnCl2, 0,211 g/L di H3BO3, 0,01 g/L CuSO4, 
0,005g/L Na2MoO4, 0,005 g/L di CoCl2, 0,014  g/L di 
ZnCl2 (Allen, 1968) e dove detto terreno di coltura ha 
pH 1,5, preferibilmente ottenuto con H2SO4. 
Secondo una forma preferita di realizzazione di 
tale metodo di estrazione, l’omogeneizzazione della 
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fase c) avviene in un mortaio con PBS 1X (tampone 
fosfato salino). Alternativamente, possono essere 
utilizzati tamponi salini differenti (come citrati, 
carbonati, bicarbonati, acetati, tricina, HEPES) e 
metodi automatizzati, come frullatori, lame d’acciaio 
collegati a motori o omogeneizzatori da laboratorio. 
Preferibilmente, l’allestimento delle colture 
cellulari di Galdieria, preferibilmente Galdieria 
sulphuraria, e crescita delle cellule in coltura 
liquida nella fase a) sono in eterotrofia: la crescita 
delle cellule può essere condotta rispettando un 
rapporto inoculo/medium di 1:4 (per esempio inoculando 
200 ml di sospensione di cellule in 1L di mezzo). La 
coltura viene poi areata per mezzo di una pompa ad aria 
e/o di un agitatore a pale rotanti, che oltre a 
garantire il sufficiente apporto di ossigeno (O2) per 
la crescita, permettono anche di mantenere omogeneo il 
mezzo di crescita ed evitare fenomeni di addensamento 
della coltura sul fondo. La crescita delle cellule 
viene condotta ad una temperatura variabile tra 26°C e 
37°C, al buio. Dopo circa 3 settimane si raggiunge la 
corretta densità (6 g/L) e le cellule, dopo il 
controllo al microscopio, possono essere raccolte per 
il processamento. 
Secondo una forma preferita di realizzazione del 
metodo secondo l’invenzione, prima della separazione 
dal mezzo di crescita, le cellule possono ulteriormente 
essere sottoposte ad almeno un trattamento selezionato 
tra: trattamento di tipo fisico, scelto tra trattamento 
al calore, al freddo o irradiazione UV; e/o trattamento 
di tipo chimico, con almeno un composto scelto tra 
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proteine, lipidi, zuccheri, sali, piccole molecole 
organiche, o loro combinazioni. Questi trattamenti 
hanno lo scopo di stimolare nelle cellule la produzione 
di metaboliti secondari di interesse e aumentare così 
l’efficacia cosmetica degli estratti derivati dalla 
microalga. 
La separazione delle cellule dal mezzo di crescita 
della fase b), può essere effettuata mediante 
centrifugazione in continuo da 1000 a 5000 g, 
preferibilmente tra 3000 e 4000 g e ancora più 
preferibilmente a 3300 g, o sedimentazione e successiva 
filtrazione mediante membrane con porosità non 
superiore ai 10 micron. Le cellule vengono poi lavate 
in una soluzione fisiologica o PBS e asciugate per 
rimuovere l’acqua presente. In alternativa il pellet 
(sedimento di centrifugazione) delle cellule può essere 
liofilizzato in modo da rimuovere completamente tutta 
l’acqua presente. 
Nella fase c) il pellet di cellule viene omogeneizzato 
in presenza di PBS 1X (NaCl 136 mM, KCl 2,7 mM, NaH2PO4 
12 mM, KH2PO4 1,76 mM, pH 7,4), preferibilmente in 
rapporto di 2:1 volume/peso. In questo passaggio, la 
sabbia di silice può essere utilizzata per facilitare 
la rottura delle cellule. L’omogeneizzazione può essere 
effettuata in un contenitore idoneo, quale un mortaio 
di ceramica e con un pestello anch’esso di ceramica, 
precedentemente raffreddati. Per volumi superiori a 200 
g si possono utilizzare recipienti più grandi, anche 
metallici, dove le cellule possono essere omogeneizzate 
con lame metalliche, utilizzando omogeneizzatori da 
laboratorio o industriali, frullatori o presse. 
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Nella fase d), si ha l’ottenimento dell'estratto 
idrosolubile: una volta ottenuto un lisato cellulare 
omogeneo tramite l’omogeneizzazione dello stadio c), il 
campione di cellule viene centrifugato, ad esempio con 
un valore di rpm compreso tra 4.000 e 8.000 rpm per 
circa 15 minuti a 4 oC, per precipitare le componenti 
insolubili. 
Il sopranatante ottenuto dalla centrifugazione 
viene prelevato: esso costituisce l'estratto 
idrosolubile dell’invenzione.  
L’estratto ottenuto nella fase d) può essere 
portato a secco (è sottoposto ad essiccazione) in un 
liofilizzatore o in una camera di essiccazione o in uno 
spray-dryer per eliminare l’acqua. 
In una forma preferita dell’invenzione l’estratto 
secco ottenuto con il metodo dell’invenzione è diluito 
in un solvente organico, preferibilmente ad una 
concentrazione variabile tra lo 0,1 e 10% p/v. 
L’estratto secco viene preferibilmente diluito in 
una miscela di glicerolo e acqua, preferibilmente in un 
rapporto preferito di 50:1, preferibilmente ad una 
concentrazione variabile tra lo 0,1 e 10% p/v. 
Alternativamente al glicerolo, l’estratto secco 
ottenuto con il metodo dell’invenzione è diluito ad una 
concentrazione variabile tra lo 0,1 e 10% p/v in un 
altro solvente organico compatibile con le formulazioni 
cosmetiche, come un solvente stearato, palmitato e/o 
butilen-glicole. 
Queste soluzioni contenenti l’estratto 
liofilizzato/essiccato rappresentano la materia prima 
che può essere utilizzata, opportunamente diluita, 
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nelle formulazione dei prodotti cosmetici finiti. 
Inoltre, le suddette cellule di microalga di 
Galdieria, preferibilmente Galdieria sulphuraria, 
possono essere precedentemente indotte da specifici 
trattamenti e condizioni di crescita per produrre 
maggiori quantità di composti attivi (es. ad azione 
seboregolatoria o in generale benefica sulle cellule 
della pelle), prima di essere sottoposte al 
procedimento di estrazione.  
Costituisce quindi un secondo aspetto della 
presente invenzione l’estratto idrosolubile ottenibile 
mediante il processo a)-d). 
In particolare, l’estratto ottenibile secondo il 
metodo dell’invenzione può essere utilizzato per il 
trattamento e/o la prevenzione cosmetica della 
iperseborrea, dell’acne e/o della pelle tendente 
all’acne. 
Inoltre, costituisce un terzo aspetto della 
presente invenzione una composizione comprendente 
l’estratto idrosolubile ottenuto mediante il processo 
a)-d) come sopra definito.  
In particolare, detta composizione può essere 
utilizzata per il trattamento e/o la prevenzione 
cosmetica della seborrea, dell’acne e/o della pelle 
tendente all’acne. 
Detto estratto idrosolubile ottenibile mediante il 
processo a)-d) può essere compreso in un veicolo 
cosmeticamente accettabile, eventualmente insieme ad 
eccipienti e/o adiuvanti cosmeticamente accettabili. 
Veicoli preferiti che possono essere impiegati 
sono liposomi, preferibilmente liposomi multilamellari, 
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ciclodestrine e/o silicati. 
Secondo un aspetto preferito, le composizioni 
dell’invenzione che comprendono un estratto ottenibile 
con il metodo dell’invenzione sono in una qualsiasi 
forma galenica per l’applicazione cutanea, 
preferibilmente in forma di crema, gel, lozione, 
soluzione, dispersione, emulsione O/A, emulsione A/O, 
latte, shampoo, sapone, stick, matita, spray, olio. 
Secondo un aspetto maggiormente preferito, le 
composizioni dell’invenzione possono essere in forma di 
creme, gel, lozioni cosmetiche per l’applicazione 
cutanea. 
Costituisce un quarto aspetto della presente 
invenzione l’uso cosmetico dell’estratto come sopra 
definito. 
In particolare, detto estratto e/o la composizione 
cosmetica che lo comprende, può essere utilizzato per 
ridurre (inibire) l’attività dell’enzima 5α-reduttasi 
e/o stimolare le difese dell’organismo contro agenti 
patogeni e/o combattere l'insorgenza dell'acne. 
Costituisce un ulteriore aspetto dell’invenzione 
un estratto ottenibile secondo il metodo 
dell’invenzione o una composizione che lo comprende, 
per l’uso nell’inibizione dell’enzima 5α-reduttasi a 
livello cutaneo e/o nella stimolazione delle difese 
dell’organismo a livello cutaneo contro agenti 
patogeni. 
Costituisce un ulteriore aspetto dell’invenzione 
un estratto ottenibile secondo il metodo 
dell’invenzione o una composizione che lo comprende, 
per l’uso nella prevenzione e/o nel trattamento della 
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caduta dei capelli. 
Costituisce un ulteriore aspetto dell’invenzione 
un metodo di trattamento cosmetico per alleviare gli 
effetti dannosi dell'acne, comprendente l’applicazione 
sulla cute in necessità di trattamento di una quantità 
cosmeticamente efficace di una composizione cosmetica 
come sopra definita, preferibilmente contenente 
concentrazioni da 0.1 a 2% di ingrediente attivo, 
costituito dall’estratto della microalga diluito in 
solvente organico. 
La presente invenzione verrà ora descritta a 
titolo illustrativo, ma non limitativo, secondo sue 
forme preferite di realizzazione con particolare 
riferimento alle figure dei disegni allegati, in cui: 
- la figura 1 riporta il grafico del saggio di 
citotossicità (MTT) che mostra come l’estratto 
idrosolubile di Galdieria sulphuraria ottenuto con il 
metodo dell’invenzione non abbia effetto tossico sui 
cheratinociti a concentrazioni uguali o inferiori a 
0,01 % p/v (1 mg/ml). In ordinata è riportato il numero 
di cellule vitali espresso in valore percentuale 
rispetto al controllo, uguale a 100%. 
- la figura 2 mostra l’analisi dell’espressione 
genica della 5-α reduttasi (a due diverse 
concentrazioni di estratto secco dell’invenzione : 
0,002% e 0,01% p/v) dopo 6 ore dal trattamento con l' 
estratto di G. sulphuraria rispetto ad un campione di 
controllo non trattato; i valori riportati nel grafico 
sono espressi come percentuali rispetto al campione del 
controllo non trattato (stabilito arbitrariamente come 
100%).  
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- la figura 3 mostra l'effetto dell'estratto di G. 
sulphuraria sulla crescita dei batteri Staphyilococcus 
epidermidis, Staphylococcus aureus e Propionibacterium 
acnes. Sull'asse delle y sono riportati i valori di 
crescita dei batteri espressi come percentuali rispetto 
al campione di controllo non trattato (stabilito 
arbitrariamente come 100%).  
- la figura 4 mostra l'effetto dell'estratto di G. 
sulphuraria (a due diverse concentrazioni: 0,002% e 
0,01% p/v) sulla espressione della β-defensina 2, dopo 
6 ore di trattamento; i valori riportati nel grafico 
sono espressi come percentuali rispetto al campione di 
controllo stabilito arbitrariamente come 100%. 
- la figura 5 mostra l'effetto dell'estratto di G. 
sulphuraria sulla rimarginazione di una ferita simulata 
in cellule in coltura. Sull'asse delle Y è riportata la 
riduzione delle dimensioni della ferita in cellule 
trattate con l'estratto della microalga e confrontata 
con quella in cellule di controllo non trattate, 
stabilita arbitrariamente come 100%. 
A titolo esemplificativo, ma non limitativo della 
presente invenzione, si riportano di seguito alcuni 
esempi relativi alla preparazione dell’estratto idro-
solubile ottenuto da cellule di G. sulphuraria, ed alla 
loro attività biologica in campo cosmetico. 
ESEMPIO 1 
Preparazione dell’estratto idrosolubile ottenuto 
da cellule di G. sulphuraria e saggi biologici per 
valutare le sue proprietà in campo cosmetico.  
 
MATERIALI E METODI 
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Estrazione della miscela idrosolubile dalle 
cellule di Galdieria sulphuraria: 
100 g di cellule di G. sulphuraria sono state 
risospese in due volumi di PBS 1X (NaCl 136 mM, KCl 2,7 
mM, NaH2PO4 12 mM, KH2PO4 1,76 mM, pH 7,4) ed 
omogeneizzate in un frullatore meccanico. 
L’omogeneizzato è stato centrifugato a 4000 rpm per 15 
min a 4°C e il sopranatante prelevato e congelato a –
80°C: esso costituisce l’estratto idrosolubile. 
L'estratto è stato poi liofilizzato in modo da ottenere 
una polvere, che è stata risospesa in acqua alla 
concentrazione variabile tra 10 e 1% p/v per eseguire i 
saggi biologici.  
L’estratto è stato testato su cellule HaCaT (linea 
di cheratinociti umani) per stabilirne le dosi di 
utilizzo e la tossicità. L’estratto è stato poi 
utilizzato in saggi cellulari specifici per valutare la 
sua attività cosmetica come seboriduttore, 
antibatterico, per la sua capacità di innalzare la 
risposta immunitaria di difesa della pelle e di 
accelerare la rimarginazione di una ferita. 
Saggio di citotossicità 
Questo saggio si basa sull'uso del MTT [3-(4,5-
dimetiltiazolil)-2,5-difeniltetrazoliobromuro]descritto 
da Mosmann nel 1983 per la prima volta. E’ basato sulla 
capacità dell'enzima deidrogenasi mitocondriale delle 
cellule vitali di idrolizzare l'anello tetrazolico del 
MTT (di colore giallo chiaro) e formare cristalli di 
formazano (di colore blu scuro). Tali cristalli sono 
impermeabili alle membrane cellulari e si accumulano 
nel citoplasma delle cellule metabolicamente attive. Il 
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numero di cellule vive e sane è così direttamente 
proporzionale al livello di formazan prodotto. 
Cellule HaCaT, in numero iniziale di 1 x 104 per 
pozzetto, sono state fatte crescere in piastre da 96 
pozzetti in mezzo di coltura DMEM (Dulbecco's Modified 
Eagle Medium) (Lonza), supplementato con il 10% di 
Fetal Bovine Serum, per circa 8 ore. Dopo il 
trattamento con concentrazioni crescenti dell’estratto 
per circa 48 ore, le cellule sono state lavate in PBS 
ed incubate con 100 ul/pozzetto di “tampone di 
reazione” contenente: 10 mM di Hepes, 1,3 mM CaCl2, 1 
mM MgSO4, 5 mM di glucosio e 0,5 mg/ml di substrato 
colorimetrico MTT in tampone PBS a pH 7,4. Dopo 3 ore 
di incubazione a 37°C, 5% CO2, ad ogni pozzetto sono 
stati aggiunti 100 µl di soluzione solubilizzante 
contenente 10% di Triton X100, 0,1 N di HCl in 
isopropanolo assoluto. Dopo 2 ore, la reazione 
colorimetrica è stata misurata a 595 nm con il lettore 
di piastre Victor3. 
Analisi dell'espressione dei geni 5-α reduttasi e 
della beta defensine 2 in cellule trattate con 
l’estratto: 
Per l’analisi dell’espressione del gene 5-α 
reduttasi (SRD5A1) sono stati utilizzati fibroblasti 
primari neonatali, mentre per il gene per le la beta 
defensine 2 (hBD2) sono stati utilizzati cheratinociti 
umani immortalizzati (HaCat). 
Fibroblasti primari neonatali (HDFn) o 
Cheratinociti immortalizzati (HaCaT) in numero iniziale 
di 1,2 x 105 per pozzetto, sono stati cresciuti in 
piastre da 6 pozzetti in mezzo di coltura DMEM (Lonza), 
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supplementato con il 10% di Fetal Bovine Serum per 16 
ore. 
Le cellule sono state poi incubate con due diverse 
concentrazioni dell'estratto della microalga per 6 ore 
(come di seguito descritto). Al termine 
dell’incubazione, le cellule sono state raccolte e 
l’RNA estratto utilizzando un kit acquistato dalla 
Sigma. I campioni di RNA sono stati sottoposti ad un 
trattamento con DNasi I (Ambion) per eliminare il DNA 
genomico contaminante. 2 µl di ciascun campione sono 
stati caricati su gel di agarosio 1% in presenza di 
“loading dye” (0,25% Blu di bromofenolo, 0.25% xilene 
cianolo FF, 40% saccarosio in acqua) e quantizzati 
utilizzando come riferimento uno specifico marker per 
RNA (Riboruler RNA ladder, Fermentas). Per la 
quantificazione è stato usato il software Gene tools 
(Perkin Elmer). 300 ng di RNA totale è stato 
retrotrascritto usando l’enzima Trascrittasi Inversa 
(Fermentas).  
Le reazioni di RT-PCR semiquantitativa sono state 
condotte utilizzando come standard interni la coppia di 
primer universali 18S primer/competimer (Ambion) in 
rapporto 3:7 per SRD5A1 e 2:8 per hBD2. I prodotti di 
PCR sono stati separati su gel d’agarosio 1,5%, 
visualizzati utilizzando lo strumento Geliance (Perkin 
Elmer) ed analizzati densitometricamente utilizzando il 
software Genetools. I valori riportati nei grafici 
delle figure 2 e 4 rappresentano i rapporti tra 
l’intensità della banda relativa al gene in analisi e 
quella della banda relativa allo standard di 
riferimento 18S, in modo da avere un valore correlato 
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alla reale espressione di quel gene e non dipendente 
dalla quantità di RNA o di reagenti di PCR presenti in 
quel campione. 
La sequenza dei primers specifici per 
l'amplificazione è la seguente: 
SRD5A1-Fw: ATGTTCCTCGTCCACTACGG 
SRD5A1-Rv: GGAGGTACCACTCATGATGC  
hBD2-Fw: ATGAGGGTCTTGTATCTCCT 
hBD2-Rv: TCATGGCTTTTTGCAGCATT 
Saggio di crescita batterica 
Per la crescita batterica di S.aureus e 
S.epidermidis, che crescono in condizioni di aerobiosi, 
è stato seguito il seguente protocollo: 
una colonia di batteri è stata fatta crescere per 18 
ore a 37°C in agitazione nel mezzo di coltura triptone 
soia (Sigma-Aldrich). La coltura è stata 
successivamente diluita 1:50 in mezzo di coltura fresco 
e 100 µl della diluizione sono stati distribuiti in 
piastra da 96 pozzetti in presenza di differenti 
concentrazioni (da 0,01% a 2,5% p/v di estratto secco 
dell'estratto della microalga. La piastra è stata 
incubata a 37°C in agitazione per 18 ore. La crescita 
batterica è stata misurata a 595 nm, usando un lettore 
di piastre Victor 3 (PerkinElmer). 
Per la crescita di P.acnes che cresce in 
anaerobiosi, quindi in assenza di ossigeno, è stato 
seguito il seguente protocollo. Una colonia di P.acnes 
è stata cresciuta in Reinforced Clostridium Medium 
(Oxiod) a 37 °C fino a raggiungere OD600=1.0 in 
condizioni di anaerobiosi usando il sistema Anaerogen 
AN 0025A (Oxiod). Successivamente 100 ul della coltura 
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sono stati distribuiti in piastra da 96 pozzetti in 
presenza di differenti concentrazioni (da 0,01% a 2,5%  
p/v di estratto secco  dell’estratto della microalga. 
La piastra è stata incubata a 37° per 18 ore in 
condizioni di anaerobiosi usando il sistema Anaerogen 
Wzip Compact (Oxiod). La crescita dei batteri è stata 
misurata a 595nm, usando il lettore di piastra Victor 3 
(PerkinElmer).  
Saggio sulla rimarginazione della ferita. 
Cellule HDFn, in numero iniziale di 1,5 x 105 per 
pozzetto, sono state fatte crescere in piastre da 6 
pozzetti in mezzo di coltura DMEM (Lonza), 
supplementato con il 10% di Fetal Bovine Serum (FBS) 
per 12 ore, affinchè raggiungano la confluenza e si 
distribuiscano uniformemente su tutta la superficie del 
pozzetto. 
Con la punta di una pipetta si genera una ferita 
interrompendo la continuità dello strato cellulare. 
Le cellule vengono sottoposte ad un lavaggio con 
un tampone salino, PBS, per rimuovere quelle staccate 
in seguito al taglio. Dopo il trattamento con 0,01 e 
0,002% dell'estratto secco della microalga per 7 ore in 
un mezzo di coltura DMEM (Lonza), supplementato con 
0,5% di FBS e 10 µg/ml di mytomycin C: quest’ultimo 
componente viene aggiunto alle cellule per bloccarne la 
proliferazione e valutarne solo la migrazione. L'area 
delimitata dai bordi delle cellule, che rappresenta la 
ferita, viene misurata al tempo 0 ed a 7 ore dal 
trattamento con il software Image J (Wayne Rasband, 
National Instituite of Heath, USA), e comparata con 
quella dei campioni di cellule non trattate. La 
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migrazione delle cellule porta ad una riduzione 
dell'area delimitata, riduzione che viene stabilita 
arbitrariamente pari al 100% nelle cellule di controllo 
non trattate.  
 
RISULTATI 
Studio della citotossicità degli estratti di 
microalga  Galdieria sulphuraria. 
Allo scopo di determinare le concentrazioni di estratto 
da utilizzare per tutti i successivi saggi, sono stati 
condotti esperimenti di citotossicità. Sono state 
saggiate tre concentrazioni dell'estratto secco, 
comprese tra 0,0025 e 0,04% (da 25 a 400 µg/ml) su 
cheratinociti HaCaT. Come mostrato nella Figura 1, 
l’estratto risulta non avere alcun effetto tossico 
sulle cellule a partire da concentrazioni inferiori o 
uguali allo 0,01%. 
 
Studio dell'effetto dell’estratto di Galdieria 
sulphuraria sull'espressione del gene 5 α-reduttasi I, 
enzima chiave nella produzione del sebo. 
Allo scopo di valutare la capacità dell’estratto 
di influenzare la produzione di sebo, sono stati 
condotti esperimenti di RT-PCR per valutare i livelli 
di espressione dell’enzima responsabile della sua 
produzione nella ghiandola sebacea, la 5α-reduttasi I. 
Per l’analisi dell’espressione, le cellule sono state 
trattate con due diverse concentrazioni dell'estratto 
secco della microalga (0,002%, 0,01%) per 6 ore. Dopo 
il trattamento, le cellule sono state raccolte, l’RNA 
estratto e l’espressione genica analizzata mediante RT-
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PCR. Come si evince dalla Figura 2, il trattamento con 
l'estratto  idrosolubile ha ridotto significativamente 
l' espressione del gene 5α−reduttasi ad entrambe le 
concentrazioni utilizzate: la concentrazione più alta 
(0,01%) produce una riduzione dell'espressione del gene 
pari a circa il 45%. Questo risultato suggerisce che il 
trattamento con l'estratto, riducendo espressione del 
gene 5α−reduttasi, possa ridurre la produzione di sebo 
sulla pelle. 
 
Studio della capacità dell’estratto di Galdieria 
sulphuraria di inibire la crescita batterica. 
L'aumento della produzione di sebo porta ad una 
crescita incontrollata di batteri che normalmente 
colonizzano la ghiandola sebacea. Allo scopo quindi di 
valutare la capacità dell'estratto di inibire la 
crescita batterica, sono stati condotti esperimenti su 
Staphylococcus epidermidis e Propionibacterium acnes, 
batteri presenti nella ghiandola sebacea, e su 
Staphylococcus aureus, batterio patogeno che causa 
foruncoli. 
I batteri sono stati fatti crescere in presenza di 
concentrazioni da 0,01 a 2,5% dell'estratto secco della 
microalga per 16 ore e la loro crescita, quantificata 
mediante lettura spettofotometrica a 595 nm, è stata 
confrontata con quella dei batteri cresciuti in assenza 
di composti.  
Come si evince dalla figura 3, l'estratto è capace 
di inibire totalmente la crescita di S. epidermidis 
alla concentrazione di 2,5%, e di ridurre la crescita 
di S.aureus e P.acnes del 35% alla stessa 




Studio della capacità dell’estratto di Galdieria 
sulphuraria di stimolare i meccanismi di difesa della 
pelle. 
Allo scopo di valutare la capacità dell’estratto 
di stimolare l’espressione di geni coinvolti nella 
risposta immunitaria innata della pelle, sono stati 
condotti esperimenti di RT-PCR per valutare i livelli 
di espressione della beta-defensina 2, uno dei peptidi 
antimicrobici prodotto dai cheratinoci. 
Per l’analisi dell’espressione, le cellule HaCaT sono 
state trattate con due diverse concentrazioni 
dell'estratto secco della microalga (0,002%, 0,01%) per 
6 ore. Dopo il trattamento, le cellule sono state 
raccolte, l’RNA estratto e l’espressione genica 
analizzata mediante RT-PCR. 
Come si evince dalla Figura 4, il trattamento con 
l'estratto idrosolubile stimola significativamente l' 
espressione del gene della beta defensina-2 ad entrambe 
le concentrazioni utilizzate: la concentrazione più 
bassa (0,002%) produce un effetto più evidente 
sull'espressione del gene, inducendo un aumento 
dell’espressione pari a circa il 160%. Questo risultato 
suggerisce che il trattamento con l'estratto, 
stimolando l’espressione del gene hβD-2, innalza i 
meccanismi di difesa dell’organismo, combattendo la 
crescita dei batteri e richiamando le cellule del 
sistema immunitario. 
Studio della capacità dell'estratto di Galdieria 
sulphuraria di rimarginare una ferita. 
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Sulla base della capacità dell’estratto di 
aumentare l’espressione della beta-defensina 2, è stata 
valutata anche la capacità dell’estratto di stimolare 
il processo di rimarginazione di una ferita. A questo 
scopo sono stati effettuati esperimenti di “wound 
healing” (rimarginazione delle ferite) su fibroblasti 
primari in piastra. Le cellule “ferite”, come descritto 
nella sezione materiali e metodi, sono state trattate 
per 7 ore con 0,01 e 0,002% di estratto secco della 
microalga G. sulphuraria e la dimensione della ferita è 
stata valutata mediante misurazione dell’area 
delimitata dalla ferita stessa. Come mostrato in figura 
5, l’estratto di G. sulphuraria è capace di ridurre la 
grandezza della ferita di circa il 20%  rispetto alla 
dimensione della ferita delle cellule di controllo non 
trattate. 
Questo risultato suggerisce che l’estratto è in 
grado di stimolare il processo di rimarginazione di una 
ferita, proprietà importante nella patologia dell’acne, 
che causa spesso significative lesioni dovute alla 
formazione di pustole e foruncoli. 
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RIVENDICAZIONI 
1. Metodo per ottenere un estratto idrosolubile 
da cellule in coltura liquida della microalga 
Galdieria, preferibilmente della specie G. sulphuraria, 
comprendente le seguenti fasi a)-g): 
a) allestimento delle colture algali monospecifiche di 
Galdieria e crescita delle cellule in coltura liquida 
in un appropriato terreno di coltura; 
b) separazione delle cellule dal mezzo di crescita; 
c) omogeneizzazione delle cellule;  
d) centrifugazione dell'omogenato per isolare 
l'estratto idrosolubile, rappresentato dal 
sopranatante. 
2. Metodo secondo la rivendicazione 1, in cui la 
microalga Galdieria, preferibilmente della specie G. 
sulphuraria, è fatta crescere nella fase a) in 
eterotrofia ad una temperatura compresa tra 26 e 37° C. 
3. Metodo secondo una qualsiasi delle 
rivendicazioni precedenti, in cui il terreno di coltura 
della fase a) comprende 1,32 g/L di (NH4)2SO4, 0,6 g/L 
di K2HPO4, 0,1 g/L di NaCl, 0,3 g/L di MgSO4, 0,00996 
g/L di FeSO4, 0,02 g/L di CaCl2, 30 g/L glucosio, 
0,0199 g/L di MnCl2, 0,211 g/L di H3BO3, 0,01 g/L CuSO4, 
0,005g/L Na2MoO4, 0,005 g/L di CoCl2, 0,014 g/L di ZnCl2 
e dove detto terreno di coltura ha pH 1,5. 
4. Metodo secondo una qualsiasi delle 
rivendicazioni precedenti, in cui detta fase c) avviene 
in un mortaio con PBS 1X. 
5. Metodo secondo una qualsiasi delle 
rivendicazioni precedenti, in cui l’estratto 
idrosolubile ottenuto dalla fase d) è sottoposto ad 
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essiccazione. 
6. Metodo secondo una qualsiasi delle 
rivendicazioni precedenti, in cui le cellule sono 
ulteriormente sottoposte ad almeno un trattamento 
scelto tra un trattamento di tipo fisico, come 
riscaldamento, raffreddamento o irradiazione UV; e/o un 
trattamento di tipo chimico con almeno un composto 
scelto tra: proteine, lipidi, zuccheri, sali, piccole 
molecole organiche o loro combinazioni. 
7. Estratto idrosolubile ottenibile con il 
metodo secondo una qualsiasi delle precedenti 
rivendicazioni. 
8. Estratto idrosolubile secondo la rivendicazione 
7, compreso in un veicolo cosmeticamente accettabile, 
eventualmente insieme ad eccipienti e/o adiuvanti 
cosmeticamente accettabili. 
9. Estratto idrosolubile secondo la rivendicazione 
8, in cui il veicolo cosmeticamente accettabile è un 
liposoma, preferibilmente un liposoma multi lamellare, 
una ciclodestrina e/o un silicato. 
10. Composizione cosmetica comprendente un 
estratto secondo una qualsiasi delle rivendicazioni 7-
9. 
11. Composizione secondo la rivendicazione 10 in 
una qualsiasi forma galenica per l’applicazione cutanea, 
preferibilmente in forma di crema, gel, lozione, 
soluzione, dispersione, emulsione O/A, emulsione A/O, 
latte, shampoo, sapone, stick, matita, spray, olio. 
12. Uso dell’estratto secondo una qualsiasi delle 
rivendicazioni 7-9 o della composizione secondo una 
qualsiasi delle rivendicazione 10-11 in campo 
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cosmetico. 
13. Uso cosmetico secondo la rivendicazione 12 per 
il trattamento dell’acne, della iperseborrea e/o della 
pelle tendente all’acne. 
14. Estratto secondo una qualsiasi delle 
rivendicazioni 7-9 o composizione definita secondo una 
qualsiasi delle rivendicazione 10-11, per l’uso nella 
prevenzione e/o il trattamento dell’acne, della 
iperseborrea e/o della pelle tendente all’acne. 
15. Estratto secondo una qualsiasi delle 
rivendicazioni 7-9 o composizione secondo una qualsiasi 
delle rivendicazione 10-11, per l’uso nell’inibizione 
dell’enzima 5α-reduttasi a livello cutaneo e/o nella 
stimolazione delle difese dell’organismo a livello 
cutaneo contro agenti patogeni. 
16. Estratto secondo una qualsiasi delle 
rivendicazioni 7-9 o composizione secondo una qualsiasi 
delle rivendicazione 10-11, per l’uso nella prevenzione 
e/o nel trattamento della caduta dei capelli. 
17. Metodo di trattamento cosmetico per alleviare 
i sintomi dell'acne, comprendente l’applicazione sulla 
cute da trattare di una quantità cosmeticamente 
efficace (da 0.0001 a 0.01% p/v) di un estratto secondo 
una qualsiasi delle rivendicazioni 7-9 o composizione 
secondo una qualsiasi delle rivendicazione 10-11. 
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Composizioni cosmetiche comprendenti estratti 
derivati dalla microalga Galdieria sulphuraria, 
particolarmente indicate per ridurre gli effetti 
dannosi causati dall’acne.  
 
RIASSUNTO 
La presente invenzione si riferisce all’uso in 
campo cosmetico di estratti cellulari derivati dalla 
microalga rossa appartenente al genere Galdieria, 
preferibilmente alla specie G. sulphuraria e alle 
relative composizioni dermocosmetiche comprendenti 
detti estratti aventi effetti seboregolatori, 
antibatterici e di stimolazione del sistema di difesa 
della pelle, utili per alleviare gli effetti dannosi 
causati dall’acne sulla pelle. L’invenzione concerne 
ulteriormente un metodo per ottenere i suddetti 
estratti. 
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